<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Front Pediatr</journal-id><journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id><journal-title-group><journal-title>Frontiers in Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2296-2360</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40013110</article-id><article-id pub-id-type="pmc">PMC11861557</article-id><article-id pub-id-type="doi">10.3389/fped.2025.1448507</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pediatrics</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Use of a specialized peptide-based enteral formula containing medium-chain triglycerides for enteral tube feeding in children with cerebral palsy and previous tube feeding intolerance on standard enteral formula: a prospective observational TolerUP study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kansu</surname><given-names>Aydan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/778124/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Kutluk</surname><given-names>Gunsel</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="an1" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Caltepe</surname><given-names>Gonul</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Arikan</surname><given-names>Cigdem</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Urganci</surname><given-names>Nafiye</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1353440/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Tumgor</surname><given-names>Gokhan</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Yuce</surname><given-names>Aysel</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1349349/overview"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Tuna Kirsaclioglu</surname><given-names>Ceyda</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2283237/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Demir</surname><given-names>Arzu Meltem</given-names></name><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><xref rid="an1" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2925192/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Demirbas</surname><given-names>Fatma</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Usta</surname><given-names>Merve</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Yavuz</surname><given-names>Sibel</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Demirtas Guner</surname><given-names>Duygu</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Gumus</surname><given-names>Ersin</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Dalgic</surname><given-names>Buket</given-names></name><xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1349354/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Dogan</surname><given-names>Yasar</given-names></name><xref rid="aff10" ref-type="aff">
<sup>10</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Gerenli</surname><given-names>Nelgin</given-names></name><xref rid="aff11" ref-type="aff">
<sup>11</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Kocamaz</surname><given-names>Halil</given-names></name><xref rid="aff12" ref-type="aff">
<sup>12</sup>
</xref><xref rid="an1" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/714314/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Gulerman</surname><given-names>Fulya</given-names></name><xref rid="aff13" ref-type="aff">
<sup>13</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Sag</surname><given-names>Elif</given-names></name><xref rid="aff14" ref-type="aff">
<sup>14</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Alptekin Sarioglu</surname><given-names>Aysugul</given-names></name><xref rid="aff15" ref-type="aff">
<sup>15</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1349368/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Eksi Bozbulut</surname><given-names>Neslihan</given-names></name><xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2924804/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Teker Duztas</surname><given-names>Demet</given-names></name><xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Altug Demirol</surname><given-names>Hatice</given-names></name><xref rid="aff10" ref-type="aff">
<sup>10</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Celtik</surname><given-names>Coskun</given-names></name><xref rid="aff11" ref-type="aff">
<sup>11</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Gungor</surname><given-names>Olcay</given-names></name><xref rid="aff12" ref-type="aff">
<sup>12</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Demiroren</surname><given-names>Kaan</given-names></name><xref rid="aff16" ref-type="aff">
<sup>16</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Uncuoglu Aydogan</surname><given-names>Aysen</given-names></name><xref rid="aff17" ref-type="aff">
<sup>17</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Bekem</surname><given-names>Ozlem</given-names></name><xref rid="aff18" ref-type="aff">
<sup>18</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Arslan</surname><given-names>Zeynep</given-names></name><xref rid="aff13" ref-type="aff">
<sup>13</sup>
</xref><xref rid="an1" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2766777/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Cakir</surname><given-names>Murat</given-names></name><xref rid="aff14" ref-type="aff">
<sup>14</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Ekici</surname><given-names>Arzu</given-names></name><xref rid="aff19" ref-type="aff">
<sup>19</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Uyar Aksu</surname><given-names>Nihal</given-names></name><xref rid="aff17" ref-type="aff">
<sup>17</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Ecevit</surname><given-names>Cigdem</given-names></name><xref rid="aff18" ref-type="aff">
<sup>18</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Erdogan</surname><given-names>Simge</given-names></name><xref rid="aff15" ref-type="aff">
<sup>15</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1349171/overview"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><label><sup>1</sup></label><institution>Department of Pediatric Gastroenterology, Ankara University School of Medicine</institution>, <addr-line>Ankara</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff2"><label><sup>2</sup></label><institution>Department of Pediatric Gastroenterology, Kanuni Sultan Suleyman Training and Research Hospital</institution>, <addr-line>Istanbul</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff3"><label><sup>3</sup></label><institution>Department of Pediatric Gastroenterology, Ondokuz Mayis University Faculty of Medicine</institution>, <addr-line>Samsun</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff4"><label><sup>4</sup></label><institution>Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Koc University Faculty of Medicine</institution>, Istanbul, <country>T&#x000fc;rkiye</country></aff><aff id="aff5"><label><sup>5</sup></label><institution>Department of Pediatric Gastroenterology, Sisli Hamidiye Etfal Training and Research Hospital</institution>, <addr-line>Istanbul</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff6"><label><sup>6</sup></label><institution>Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cukurova University Faculty of Medicine</institution>, <addr-line>Adana</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff7"><label><sup>7</sup></label><institution>Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Hacettepe University Faculty of Medicine</institution>, <addr-line>Ankara</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff8"><label><sup>8</sup></label><institution>Department of Pediatric Gastroenterology, Ankara City Hospital</institution>, <addr-line>Ankara</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff9"><label><sup>9</sup></label><institution>Department of Pediatric Gastroenterology, Gazi University Faculty of Medicine</institution>, <addr-line>Ankara</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff10"><label><sup>10</sup></label><institution>Department of Pediatric Gastroenterology, Firat University Faculty of Medicine</institution>, <addr-line>Elazig</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff11"><label><sup>11</sup></label><institution>Department of Pediatric Gastroenterology, Istanbul Umraniye Training and Research Hospital</institution>, <addr-line>Istanbul</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff12"><label><sup>12</sup></label><institution>Department of Pediatrics, Division of Pediatric Gastroenterology, Pamukkale University Faculty of Medicine</institution>, <addr-line>Denizli</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff13"><label><sup>13</sup></label><institution>Department of Pediatric Gastroenterology, Kirikkale University Faculty of Medicine</institution>, <addr-line>Kirikkale</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff14"><label><sup>14</sup></label><institution>Department of Pediatric Gastroenterology Hepatology and Nutrition, Karadeniz Technical University Faculty of Medicine</institution>, <addr-line>Trabzon</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff15"><label><sup>15</sup></label><institution>Abbott Laboratories</institution>, <addr-line>Istanbul</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff16"><label><sup>16</sup></label><institution>Department of Pediatric Gastroenterology, Bursa Yuksek Ihtisas Training and Research Hospital</institution>, <addr-line>Bursa</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff17"><label><sup>17</sup></label><institution>Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Kocaeli University Faculty of Medicine</institution>, <addr-line>Kocaeli</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff18"><label><sup>18</sup></label><institution>Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Health Sciences Dr. Behcet Uz Children's Hospital</institution>, <addr-line>Izmir</addr-line>, <country>T&#x000fc;rkiye</country></aff><aff id="aff19"><label><sup>19</sup></label><institution>Department of Pediatric Neurology, Bursa Yuksek Ihtisas Training and Research Hospital</institution>, <addr-line>Bursa</addr-line>, <country>T&#x000fc;rkiye</country></aff><author-notes><fn fn-type="edited-by"><p><bold>Edited by:</bold> Andrew S. Day, University of Otago, New Zealand</p></fn><fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Stephanie Brown, University of Otago, New Zealand</p><p>Mustapha Mouilly, Ibn Tofail University, Morocco</p></fn><corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Aydan Kansu <email>aydankansu@gmail.com</email></corresp><fn fn-type="present-address" id="an1"><label>
<sup>&#x02020;</sup>
</label><p><bold>Present Addresses:</bold> Gunsel Kutluk,Department of Pediatric Gastroenterology, University of Health Sciences Basaksehir Cam and Sakura City Hospital, Istanbul, T&#x000fc;rkiye Arzu Meltem Demir,Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Ankara University Faculty of Medicine, Ankara, T&#x000fc;rkiye Halil Kocamaz,Department of Pediatrics, Division of Pediatric Gastroenterology, Dicle University Faculty of Medicine, Diyarbakir, T&#x000fc;rkiye Zeynep Arslan,Department of Developmental-Behavioral Pediatrics, Bilkent City Hospital, Ankara, T&#x000fc;rkiye</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>13</volume><elocation-id>1448507</elocation-id><history><date date-type="received"><day>13</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>15</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 Kansu, Kutluk, Caltepe, Arikan, Urganci, Tumgor, Yuce, Tuna Kirsaclioglu, Demir, Demirbas, Usta, Yavuz, Demirtas Guner, Gumus, Dalgic, Dogan, Gerenli, Kocamaz, Gulerman, Sag, Alptekin Sarioglu, Eksi Bozbulut, Teker Duztas, Altug Demirol, Celtik, Gungor, Demiroren, Uncuoglu Aydogan, Bekem, Arslan, Cakir, Ekici, Uyar Aksu, Ecevit and Erdogan.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Kansu, Kutluk, Caltepe, Arikan, Urganci, Tumgor, Yuce, Tuna Kirsaclioglu, Demir, Demirbas, Usta, Yavuz, Demirtas Guner, Gumus, Dalgic, Dogan, Gerenli, Kocamaz, Gulerman, Sag, Alptekin Sarioglu, Eksi Bozbulut, Teker Duztas, Altug Demirol, Celtik, Gungor, Demiroren, Uncuoglu Aydogan, Bekem, Arslan, Cakir, Ekici, Uyar Aksu, Ecevit and Erdogan</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Use of peptide-based formulas supplemented with medium chain triglycerides (MCTs) is considered a beneficial strategy to decrease the tube-feeding associated gastrointestinal tolerance. In children with cerebral palsy (CP), overall effects of enteral tube feeding as well as the utility of peptide-based specialized enteral formulas in those with gastrointestinal intolerance have not been extensively studied. This study aimed to evaluate the utility of enteral tube feeding via specialized peptide-based formula containing MCTs in children with CP in terms of gastrointestinal intolerance, anthropometrics, defecation characteristics and parental satisfaction with enteral formula.</p></sec><sec><title>Methods</title><p>Children with CP who received enteral tube feeding via specialized peptide-based formula containing MCTs were included in this prospective observational study. Anthropometrics (<italic>z</italic> scores for weight for age [WFA], weight for height [WFH], triceps skinfold thickness [TSFT] and mid-upper arm circumference [MUAC]), gastrointestinal intolerance symptoms, defecation frequency and stool patterns and formula satisfaction were recorded at baseline and during 6-month follow up.</p></sec><sec><title>Results</title><p>A total of 96 children with CP (mean&#x02009;&#x000b1;&#x02009;SD age: 5.6&#x02009;&#x000b1;&#x02009;3.2 years, 56.3% were boys) were included. Significant improvements were noted in MUAC, TSFT and WFH <italic>z</italic> scores at the 6th month visit. The rate of &#x0201c;severe symptoms&#x0201d; and the likelihood of Type-1/Type-2 (constipation) stool pattern were significantly decreased. Majority of parents were satisfied with the study formula.</p></sec><sec><title>Conclusion</title><p>Our findings revealed favorable efficacy and safety of using a specialized peptide-based formula containing MCT in provision of enteral tube feeding among children with CP in terms of improved anthropometrics, amelioration of gastrointestinal intolerance symptoms and normalization of bowel movements along with a high parental satisfaction.</p></sec></abstract><kwd-group><kwd>cerebral palsy</kwd><kwd>peptide-based formula</kwd><kwd>gastrointestinal intolerance</kwd><kwd>anthropometrics</kwd><kwd>parental satisfaction</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Abbott Nutrition Turkey</funding-source></award-group><funding-statement>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by Abbott Nutrition Turkey.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="8"/><equation-count count="0"/><ref-count count="68"/><page-count count="17"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Pediatric Gastroenterology, Hepatology and Nutrition</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Functional feeding disorders and gastrointestinal dysfunction are highly prevalent conditions in children with cerebral palsy (CP), which compromise the adequate nutrient intake in these children by causing vomiting, dysphagia, impaired swallowing, gastroesophageal reflux, aspiration and constipation, in addition to limited self-feeding ability (<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B5" ref-type="bibr">5</xref>). Accordingly, many children with CP are considered at high risk of poor nutritional status, particularly those with severe gross motor impairment and oropharyngeal dysfunction (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>).</p><p>In children with CP, malnutrition leads to growth failure, decreased cerebral function and reduced potential for development, impaired immune, respiratory and gastro-intestinal functions, delayed wound healing, increased morbidity and reduced quality of life (<xref rid="B8" ref-type="bibr">8</xref>&#x02013;<xref rid="B10" ref-type="bibr">10</xref>).</p><p>Owing to increased life-expectancy in the presence of disability, the prevalence and consequences of feeding difficulties are on the rise in children with CP, making nutritional status an indispensable part of the medical care (<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>). Hence, comprehensive evaluation and treatment of feeding disorders via adequate nutritional support based on better tolerated enteral formulas is considered essential in improving the nutritional status, anthropometrics, energy store and quality of life, as well as in decreasing irritability, spasticity and hospitalization rates in neurologically impaired children including those with CP (<xref rid="B12" ref-type="bibr">12</xref>&#x02013;<xref rid="B14" ref-type="bibr">14</xref>).</p><p>Enteral tube feeding, via nasogastric or gastrostomy tube feeding depending on the anticipated duration of enteral nutrition, is frequently indicated in children with CP with significant oropharyngeal incoordination who are unable to meet their nutritional requirements orally (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). However, feeding intolerance and related complications comprise a major drawback to enteral tube feeding in children with severe impairment of the central nervous system (<xref rid="B15" ref-type="bibr">15</xref>). The formula composition, proteins in particular, is considered critical in provision of best nutritional support in children with CP, given the persisting feeding difficulties in gastrostomy-fed children in addition to adverse effects of highly prevalent gastrointestinal symptoms (possibly related to delayed gastric emptying and gastric dysmotility) on the already impaired nutritional status (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B16" ref-type="bibr">16</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>).</p><p>The higher efficacy and better tolerability of peptide-based formulas, as compared with formulas composed entirely of free amino acids or intact protein, have been reported in malnourished patients, particularly in those with gastrointestinal dysfunction and thus inability to tolerate nutritional supplements containing whole protein or long chain triglycerides (<xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B21" ref-type="bibr">21</xref>). Patients with impaired gastrointestinal function are considered to require a formula containing hydrolyzed protein and medium chain triglycerides (MCTs) to minimize the need for hydrolysis of protein by the intestinal brush border peptidases for an easier absorption (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B22" ref-type="bibr">22</xref>). Hence, although being addressed by only a few studies in critically ill patients, use of formulas that are peptide-based and supplemented with MCT and fiber is considered amongst the potential nutritional interventions to decrease the tube-feeding associated gastrointestinal tolerance (<xref rid="B21" ref-type="bibr">21</xref>). The overall effects of enteral tube feeding as well as the utility of peptide-based specialized enteral formulas in those with gastrointestinal intolerance have not been extensively studied among children with CP (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B23" ref-type="bibr">23</xref>&#x02013;<xref rid="B25" ref-type="bibr">25</xref>).</p><p>This prospective observational study was designed to evaluate the utility of a specialized peptide-based formula containing MCT in children with CP who had previous tube feeding intolerance on standard enteral formula, in terms of effects on gastrointestinal intolerance, anthropometrics, defecation frequency and stool patterns and parental satisfaction with enteral formula.</p></sec><sec sec-type="methods" id="s2"><title>Materials and methods</title><sec id="s2a"><title>Study population</title><p>Children with CP who received enteral tube feeding with a specialized peptide-based enteral formula containing partially hydrolyzed protein plus MCTs, due to previous tube feeding intolerance on standard enteral formula, were included in this prospective observational multi-center 6-month follow up study conducted at 17 centers across Turkey. Hospitalized or outpatient children with CP (1&#x02013;12 years of age) who developed gastrointestinal intolerance on enteral tube feeding with standard enteral formula and therefore were planned to receive a specialized peptide-based enteral formula that contain partially hydrolyzed protein plus MCTs were included in the study. Presence of another chronic disease (diabetes, liver disease, kidney disease, endocrine disease, cancer), intestinal obstruction, need for dialysis treatment, artificial respiratory device, parenteral nutrition or normal nutrition in addition to enteral tube feeding were the exclusion criteria of the study. Although 126 children with CP were initially enrolled in the study, 96 children comprised the final study population, since 30 children were excluded due to protocol violation (<italic>n</italic>&#x02009;=&#x02009;13), adverse events (<italic>n</italic>&#x02009;=&#x02009;7), death (<italic>n</italic>&#x02009;=&#x02009;6), dissatisfaction with the nutritional product (<italic>n</italic>&#x02009;=&#x02009;2), withdrawal of informed consent form (<italic>n</italic>&#x02009;=&#x02009;1) and other reasons (<italic>n</italic>&#x02009;=&#x02009;1).</p><p>Written informed consent was obtained from parent/legal guardian of each subject. The study was conducted in accordance with the ethical principles stated in the &#x0201c;Declaration of Helsinki&#x0201d; and approved by the Ankara University Faculty of Medicine Clinical Research Ethics Committee (Date of Approval: 24/07/2017; Protocol No: 12-736-17) and the Republic of Turkey Ministry of Health Turkish Medicines and Medical Devices Agency (Date of approval: 16/08/2017; Protocol No: 93189304-514.05.01-E.168888).</p></sec><sec id="s2b"><title>Assessments</title><p>Data on demographic characteristics (age, gender), clinical and functional subtypes of CP and gastrointestinal intolerance symptoms were recorded at baseline. Data on clinical nutrition characteristics (type, route, mode of delivery, daily volume), total energy expenditure (TEE), anthropometrics (body mass index [BMI], weight for age [WFA], weight for height [WFH], triceps skinfold thickness [TSFT] and mid-upper arm circumference [MUAC]) expressed as <italic>z</italic> scores, gastrointestinal intolerance symptoms (severity and frequency), and defecation frequency and stool patterns were recorded at baseline and at three consecutive visits (1st, 3rd and 6th months) during a 6-month follow up. Parent's assessment on feeding and stool patterns and formula satisfaction were also evaluated via responses to the Feeding and Stool Patterns Questionnaire (at baseline and 1st, 3rd and 6th months) and Formula Satisfaction Questionnaire (at 1st, 3rd and 6th months), respectively, which were applied through face-to-face interview method.</p></sec><sec id="s2c"><title>Anthropometry</title><p>Body weight was measured using a digital baby weight scale (10&#x02005;g precision) in children aged &#x02264;2 years, while with adult electronic scale (100&#x02005;g precision) in children aged &#x0003e;2 years. Length measurement was performed using a 1&#x02005;m length measuring tape (0.1&#x02005;cm precision) in children aged &#x02264;2 years, with a wall mounted stature meter (0.2&#x02005;cm precision) in children aged &#x0003e;2 years, and with the use of tibial length (measured via a flexible tape measure from the superior border of the medial tibia condyle to the inferior border of the medial malleolus, with both the knee and the ankle at 90&#x02005;degrees) for the stature estimations when necessary (<xref rid="B26" ref-type="bibr">26</xref>). MUAC was measured from the left upper arm flexed slightly at the elbow, at half distance between the acromion and the olecranon using a plastic measuring tape. TSFT was measured from the left arm, and at half distance between the acromion and the olecranon, using a skin fold caliper. Anthropometric data were expressed as <italic>z</italic> scores for BMI, TSFT and MUAC along with estimation of mean z-scores and percentiles for WFA and WFH (<xref rid="B27" ref-type="bibr">27</xref>). Growth was assessed based on the maintenance of anthropometric z-scores (using WHO reference data) during the study (<xref rid="B28" ref-type="bibr">28</xref>).</p></sec><sec id="s2d"><title>Gastrointestinal intolerance and defecation</title><p>Gastrointestinal intolerance symptoms were evaluated in terms of frequency and severity. Symptom frequency scores ranged from 1 to 6 (1: none, 2: once a month, 3: once a week, 4: 2&#x02013;6 times in a week, 5: 1&#x02013;2 times per day and 6: &#x02265;3 times per day). Symptom severity scores were grouped as score 1&#x02013;2 (none-mild), score 3 (moderate) and score 4&#x02013;5 (severe).</p><p>Defecation frequency was evaluated in &#x0201c;at least 2&#x02013;3 times per day&#x0201d;, &#x0201c;once a day/once in 2&#x02013;3 days&#x0201d;, &#x0201c;once a week or less&#x0201d; groups. The stool patterns were evaluated using Bristol Scale as categorized into type 1&#x02013;2 (indicate constipation), type 3&#x02013;4 (ideal stools as they are easier to pass), and type 5&#x02013;7 (indicate diarrhea and urgency) (<xref rid="B29" ref-type="bibr">29</xref>).</p></sec><sec id="s2e"><title>TEE</title><p>TEE (kcal/day) was estimated using the height-based method for energy requirements of children with CP, including 15&#x02005;kcal/cm in children without motor dysfunction, 14&#x02005;kcal/cm for ambulatory children having motor dysfunction and 11&#x02005;kcal/cm for non-ambulatory children (<xref rid="B30" ref-type="bibr">30</xref>).</p></sec><sec id="s2f"><title>Statistical analysis</title><p>Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 20.0 (IBM Corp., Armonk, NY). The numerical data were analyzed using Friedman test (with pairwise comparisons via Wilcoxon test) where the repeated measurement statistics did not comply with the parametric test assumptions, while repeated measurement statistics were used otherwise. Change over time was evaluated by Wilcoxon test for non-normally distributed variables. Data were expressed as mean&#x02009;&#x000b1;&#x02009;standard deviation (SD), median (minimum&#x02013;maximum) and percent (%) where appropriate. <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3a"><title>Baseline characteristics</title><p>A total of 96 children with CP were included in the study. The mean age of children with CP was 5.6 years (SD 3.2, range 1.0&#x02013;12.0 years), and 56.3% of children were boys. Children with spastic CP (78.0%) and severe (30.4%) or total (20.7%) functional limitation comprised the majority of study population. The most common gastrointestinal intolerance symptoms recorded at baseline were gastrointestinal discomfort (65.6%), constipation (62.5%), retching (58.3%), nausea (52.8%), gas (49.5%), stomachache (42.4%) reflux/regurgitation (40.0%) and abdominal distention (37.2%) (<xref rid="T1" ref-type="table">Table&#x000a0;1</xref>).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Baseline characteristics in children with CP.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" colspan="3" rowspan="1">Patient demographics</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="2" colspan="1">Age (year)</td><td valign="top" align="left" rowspan="1" colspan="1">Mean&#x02009;&#x000b1;&#x02009;SD</td><td valign="top" align="center" rowspan="1" colspan="1">5.6&#x02009;&#x000b1;&#x02009;3.2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median (min&#x02013;max)</td><td valign="top" align="center" rowspan="1" colspan="1">5.0 (1.0&#x02013;12.0)</td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1">Gender, <italic>n</italic> (%)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Girl</td><td valign="top" align="center" rowspan="1" colspan="1">42 (43.8)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Boy</td><td valign="top" align="center" rowspan="1" colspan="1">54 (56.3)</td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1">CP classification, <italic>n</italic> (%)</td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1">Clinical classification</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Spastic</td><td valign="top" align="center" rowspan="1" colspan="1">71 (78.0)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Hemiplegia</td><td valign="top" align="center" rowspan="1" colspan="1">5 (7.0)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Diplegia</td><td valign="top" align="center" rowspan="1" colspan="1">3 (4.2)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Quadriplegia</td><td valign="top" align="center" rowspan="1" colspan="1">63 (88.7)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Extrapyramidal</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.4)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Rigidity</td><td valign="top" align="center" rowspan="1" colspan="1">3 (75.0)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Ataxia</td><td valign="top" align="center" rowspan="1" colspan="1">1 (25.0)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Mixed</td><td valign="top" align="center" rowspan="1" colspan="1">16 (17.6)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Primary spastic</td><td valign="top" align="center" rowspan="1" colspan="1">14 (87.5)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Primary extrapyramidal</td><td valign="top" align="center" rowspan="1" colspan="1">2 (12.5)</td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1">Functional classification</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">No activity limitation</td><td valign="top" align="center" rowspan="1" colspan="1">12 (13.0)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Mild activity limitation</td><td valign="top" align="center" rowspan="1" colspan="1">33 (35.9)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Severe activity limitation</td><td valign="top" align="center" rowspan="1" colspan="1">28 (30.4)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">No functional activity</td><td valign="top" align="center" rowspan="1" colspan="1">19 (20.7)</td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1">Gastrointestinal intolerance symptoms at enrolment</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Discomfort</td><td valign="top" align="center" rowspan="1" colspan="1">63 (65.6)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Constipation</td><td valign="top" align="center" rowspan="1" colspan="1">60 (62.5)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Retching</td><td valign="top" align="center" rowspan="1" colspan="1">56 (58.3)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Nausea</td><td valign="top" align="center" rowspan="1" colspan="1">47 (52.8)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Gas</td><td valign="top" align="center" rowspan="1" colspan="1">47 (49.5)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Stomachache</td><td valign="top" align="center" rowspan="1" colspan="1">28 (42.4)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Reflux/Regurgitation</td><td valign="top" align="center" rowspan="1" colspan="1">38 (40.0)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Abdominal distention</td><td valign="top" align="center" rowspan="1" colspan="1">35 (37.2)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Vomiting</td><td valign="top" align="center" rowspan="1" colspan="1">32 (33.3)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Residue</td><td valign="top" align="center" rowspan="1" colspan="1">10 (15.2)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Diarrhea</td><td valign="top" align="center" rowspan="1" colspan="1">13 (13.5)</td></tr></tbody></table></table-wrap></sec><sec id="s3b"><title>Peptide-based enteral formula characteristics</title><p>Majority of children received Pediasure peptide&#x000ae; 1.0 Cal [Abbott Nutrition; hydrolyzed whey-dominant protein; 7&#x02005;g (14% E) per 100&#x02005;ml] at baseline (90.6%, via PEG in 88.5% and via NGT in 11.5%) as well as in the 3rd month (89.6%) and 6th month (92.7%) visits. Peptisorb&#x000ae; [100% whey protein; 2.8&#x02005;g (11% E) per 100&#x02005;ml] users comprised the 9.4% (baseline and 3rd month) and 7.3% (6th month) of study population (<xref rid="T2" ref-type="table">Table&#x000a0;2</xref>). Mode of delivery included bolus injection in 59.6% of children, while pump-assisted administration and gravity-controlled administration were applied in 34.0% and 6.5% of children, respectively. Median daily total volume was 800&#x02005;ml (61.5&#x02005;ml/kg) at baseline and 1,000&#x02005;ml (63.5&#x02005;ml/kg) at the 6th month visit (<xref rid="T2" ref-type="table">Table&#x000a0;2</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Nutritional characteristics in children with CP.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="2" colspan="2"/><th valign="top" align="center" colspan="3" rowspan="1">Nutritional characteristics at baseline</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Overall</th><th valign="top" align="center" rowspan="1" colspan="1">PEG</th><th valign="top" align="center" rowspan="1" colspan="1">NGT</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="2" colspan="1">Peptide-based enteral formula, <italic>n</italic> (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Pediasure&#x000ae; peptide</td><td valign="top" align="center" rowspan="1" colspan="1">87 (90.6)</td><td valign="top" align="center" rowspan="1" colspan="1">77 (88.5)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (11.5)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Peptisorb&#x000ae;</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.4)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (100.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1">Mode of delivery, <italic>n</italic> (%)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Pump-assisted</td><td valign="top" align="center" rowspan="1" colspan="1">32 (34.0)</td><td valign="top" align="center" rowspan="1" colspan="1">29 (90.6)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (9.4)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Gravity-controlled</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.4)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (50.0)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (50.0)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Bolus injection</td><td valign="top" align="center" rowspan="1" colspan="1">56 (59.6)</td><td valign="top" align="center" rowspan="1" colspan="1">53 (94.6)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (5.4)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Duration of use (month), median (min&#x02013;max)</td><td valign="top" align="center" rowspan="1" colspan="1">11.0 (0.10&#x02013;96.0)</td><td valign="top" align="center" rowspan="1" colspan="1">12.0 (0.5&#x02013;96.0)<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">9.0 (0.10&#x02013;50.0)<sup>b</sup></td></tr><tr><th valign="top" align="left" rowspan="2" colspan="2"/><th valign="top" align="center" colspan="3" rowspan="1">Nutritional characteristics at study visits</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Baseline</th><th valign="top" align="center" rowspan="1" colspan="1">3rd month</th><th valign="top" align="center" rowspan="1" colspan="1">6th month</th></tr><tr><td valign="top" align="left" rowspan="3" colspan="1">Peptide-based enteral formula, <italic>n</italic> (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Pediasure&#x000ae; peptide</td><td valign="top" align="center" rowspan="1" colspan="1">87 (90.6)</td><td valign="top" align="center" rowspan="1" colspan="1">86 (89.6)</td><td valign="top" align="center" rowspan="1" colspan="1">89 (92.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Peptisorb&#x000ae;</td><td valign="top" align="left" rowspan="1" colspan="1">9 (9.4)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.4)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bebelac pepti junior&#x000ae;</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02014;</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Daily total volume, median (min&#x02013;max)</td><td valign="top" align="left" rowspan="1" colspan="1">ml/day</td><td valign="top" align="center" rowspan="1" colspan="1">800 (240&#x02013;1,800)</td><td valign="top" align="center" rowspan="1" colspan="1">918 (250&#x02013;1,800)</td><td valign="top" align="center" rowspan="1" colspan="1">1,000 (275&#x02013;2,000)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ml/kg</td><td valign="top" align="left" rowspan="1" colspan="1">61.5 (21.1&#x02013;153.8)</td><td valign="top" align="center" rowspan="1" colspan="1">65.5 (21.8&#x02013;148.1)</td><td valign="top" align="center" rowspan="1" colspan="1">63.5 (21.7&#x02013;166.7)</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1">TEE (kcal/day), <italic>n</italic> (%)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">15&#x02005;kcal/cm (no motor dysfunction)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.2)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">14&#x02005;kcal/cm (mobile with motor dysfunction)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (25.5)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (19.1)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (14.7)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">11&#x02005;kcal/cm (immobile)</td><td valign="top" align="center" rowspan="1" colspan="1">68 (72.3)</td><td valign="top" align="center" rowspan="1" colspan="1">73 (77.7)</td><td valign="top" align="center" rowspan="1" colspan="1">78 (82.1)</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1">Daily total volume by TEE, median (min&#x02013;max)</td></tr><tr><td valign="top" align="left" rowspan="3" colspan="1">ml/day</td><td valign="top" align="left" rowspan="1" colspan="1">15&#x02005;kcal/cm (no motor dysfunction)</td><td valign="top" align="center" rowspan="1" colspan="1">1,270 (1,000&#x02013;1,540)</td><td valign="top" align="center" rowspan="1" colspan="1">1,400 (1,200&#x02013;1,800)</td><td valign="top" align="center" rowspan="1" colspan="1">1,200 (1,000&#x02013;1,400)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">14&#x02005;kcal/cm (mobile with motor dysfunction)</td><td valign="top" align="left" rowspan="1" colspan="1">960 (480&#x02013;1,600)</td><td valign="top" align="center" rowspan="1" colspan="1">960 (420&#x02013;1,600)</td><td valign="top" align="center" rowspan="1" colspan="1">1,140 (800&#x02013;2,000)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">11&#x02005;kcal/cm (immobile)</td><td valign="top" align="left" rowspan="1" colspan="1">800 (240&#x02013;1,800)</td><td valign="top" align="center" rowspan="1" colspan="1">900 (250&#x02013;1,800)</td><td valign="top" align="center" rowspan="1" colspan="1">1,000 (275&#x02013;1,540)</td></tr><tr><td valign="top" align="left" rowspan="3" colspan="1">ml/kg</td><td valign="top" align="left" rowspan="1" colspan="1">15&#x02005;kcal/cm (no motor dysfunction)</td><td valign="top" align="center" rowspan="1" colspan="1">78.1 (27.8&#x02013;128.3)</td><td valign="top" align="center" rowspan="1" colspan="1">92.3 (47.4&#x02013;100)</td><td valign="top" align="center" rowspan="1" colspan="1">83.3 (33.4&#x02013;98.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">14&#x02005;kcal/cm (mobile with motor dysfunction)</td><td valign="top" align="left" rowspan="1" colspan="1">69.1 (27.6&#x02013;153.8)</td><td valign="top" align="center" rowspan="1" colspan="1">72.9 (36.4&#x02013;148.1)</td><td valign="top" align="center" rowspan="1" colspan="1">73.3 (22.7&#x02013;139.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">11&#x02005;kcal/cm (immobile)</td><td valign="top" align="left" rowspan="1" colspan="1">60.3 (21.1&#x02013;133.3)</td><td valign="top" align="center" rowspan="1" colspan="1">64.4 (21.8&#x02013;142.9)</td><td valign="top" align="center" rowspan="1" colspan="1">61.1 (21.7&#x02013;166.7)</td></tr></tbody></table><table-wrap-foot><fn id="table-fn1"><p>NGT, nasogastric tube; PEG, percutaneous endoscopic gastrostomy; TEE, total energy expenditure.</p></fn><fn id="table-fn2"><p>The duration of use is not specified for <sup>a</sup>16 patients and <sup>b</sup>1 patient.</p></fn></table-wrap-foot></table-wrap><p>Immobile children with 11&#x02005;kcal/cm height/day energy need comprised the majority of study population in each follow up visit (72.3%, 77.7% and 82.1%, respectively). In these children, the median daily total volume was 800&#x02005;ml (60.3&#x02005;ml/kg) at baseline and 1,000&#x02005;ml (61.1&#x02005;ml/kg) at 6th month visit (<xref rid="T2" ref-type="table">Table&#x000a0;2</xref>).</p></sec><sec id="s3c"><title>Anthropometrics at baseline and follow up visits</title><p>When compared to baseline scores, significant improvement was noted in median (min/max) MUAC <italic>z</italic> scores [&#x02212;1.14 (&#x02212;2.68/&#x02212;0.19) vs. &#x02212;1.07 (&#x02212;2.07/0.32), <italic>p</italic>&#x02009;=&#x02009;0.012], TSFT <italic>z</italic> scores [&#x02212;0.52 (&#x02212;1.29/0.40) vs. &#x02212;0.37 (&#x02212;1.05/0.92), <italic>p</italic>&#x02009;=&#x02009;0.005] and WFH <italic>z</italic> scores [&#x02212;2.0 (&#x02212;3.40/&#x02212;0.36) vs. &#x02212;1.52 (&#x02212;3.11/&#x02212;0.35), <italic>p</italic>&#x02009;=&#x02009;0.003] at 6th month visit. The change from baseline MUAC <italic>z</italic> score was also significantly higher at 3rd month visit compared to 6th month visit [0.99 (&#x02212;10.5/3.68) vs. 0.27 (&#x02212;8.41/4.38), <italic>p</italic>&#x02009;=&#x02009;0.012] (<xref rid="T3" ref-type="table">Table&#x000a0;3</xref>, <xref rid="F1" ref-type="fig">Figure&#x000a0;1</xref>).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Change in anthropometric <italic>z</italic> scores during study visits in children with CP who received a specialized peptide-based enteral formula.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" colspan="2" rowspan="1">Median (min&#x02013;max)</th><th valign="top" align="center" rowspan="1" colspan="1">Baseline</th><th valign="top" align="center" rowspan="1" colspan="1">3rd month</th><th valign="top" align="center" rowspan="1" colspan="1">6th month</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="2" colspan="1">WFA <italic>z</italic> score (<italic>n</italic>&#x02009;=&#x02009;78)</td><td valign="top" align="left" rowspan="1" colspan="1">Visit score</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.06 (&#x02212;3.41/&#x02212;0.68)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.23 (&#x02212;3.50/&#x02212;0.54)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.17 (&#x02212;3.44/&#x02212;0.60)</td><td valign="top" align="center" rowspan="1" colspan="1">0.239<xref rid="table-fn4" ref-type="table-fn"><sup>1</sup></xref></td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Change from baseline</td><td valign="top" align="center" rowspan="1" colspan="1">0.09 (&#x02212;2.9/4.04)</td><td valign="top" align="center" rowspan="1" colspan="1">0.16 (&#x02212;2.63/5.10)</td><td valign="top" align="center" rowspan="1" colspan="1">0.365<xref rid="table-fn5" ref-type="table-fn"><sup>2</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">WFH <italic>z</italic> score (<italic>n</italic>&#x02009;=&#x02009;90)</td><td valign="top" align="left" rowspan="1" colspan="1">Visit score</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.0 (&#x02212;3.40/&#x02212;0.36)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.63 (&#x02212;3.14/&#x02212;0.50)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.52 (&#x02212;3.11/&#x02212;0.35) ***</td><td valign="top" align="center" rowspan="1" colspan="1">0.360<xref rid="table-fn4" ref-type="table-fn"><sup>1</sup></xref><sup>,</sup><xref rid="table-fn6" ref-type="table-fn"><sup>3</sup></xref></td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Change from baseline</td><td valign="top" align="center" rowspan="1" colspan="1">0.06 (&#x02212;3.53/3.98)</td><td valign="top" align="center" rowspan="1" colspan="1">0.16 (&#x02212;2.57/6.09)</td><td valign="top" align="center" rowspan="1" colspan="1">0.340<xref rid="table-fn5" ref-type="table-fn"><sup>2</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">BMI <italic>z</italic> score (<italic>n</italic>&#x02009;=&#x02009;89)</td><td valign="top" align="left" rowspan="1" colspan="1">Visit score</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.3 (&#x02212;2.9/0.0)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.42 (&#x02212;3.14/&#x02212;0.06)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.14 (&#x02212;3.50/0.14)</td><td valign="top" align="center" rowspan="1" colspan="1">0.915<xref rid="table-fn4" ref-type="table-fn"><sup>1</sup></xref></td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Change from baseline</td><td valign="top" align="center" rowspan="1" colspan="1">0.09 (&#x02212;4.92/5.81)</td><td valign="top" align="center" rowspan="1" colspan="1">0.00 (&#x02212;5.40/5.84)</td><td valign="top" align="center" rowspan="1" colspan="1">0.936<xref rid="table-fn5" ref-type="table-fn"><sup>2</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">MUAC <italic>z</italic> score (<italic>n</italic>&#x02009;=&#x02009;76)</td><td valign="top" align="left" rowspan="1" colspan="1">Visit score</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.14(&#x02212;2.68/&#x02212;0.19)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.96 (&#x02212;2.11/0.27)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.07 (&#x02212;2.07/0.32)*</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0</bold>
<bold>.</bold>
<bold>006</bold>
<xref rid="table-fn4" ref-type="table-fn">
<sup>1</sup>
</xref>
</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Change from baseline</td><td valign="top" align="center" rowspan="1" colspan="1">0.99 (&#x02212;10.5/3.68)</td><td valign="top" align="center" rowspan="1" colspan="1">0.27 (&#x02212;8.41/4.38)</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0.012</bold>
<xref rid="table-fn5" ref-type="table-fn">
<sup>2</sup>
</xref>
</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">TSFT <italic>z</italic> score (<italic>n</italic>&#x02009;=&#x02009;82)</td><td valign="top" align="left" rowspan="1" colspan="1">Visit score</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.52 (&#x02212;1.29/0.40)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.34 (&#x02212;1.29/0.59)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.37 (&#x02212;1.05/0.92)**</td><td valign="top" align="center" rowspan="1" colspan="1">
<bold>0</bold>
<bold>.</bold>
<bold>028</bold>
<xref rid="table-fn4" ref-type="table-fn">
<sup>1</sup>
</xref>
</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Change from baseline</td><td valign="top" align="center" rowspan="1" colspan="1">0.005 (&#x02212;4.40/5.17)</td><td valign="top" align="center" rowspan="1" colspan="1">0.21 (&#x02212;4.33/5.25)</td><td valign="top" align="center" rowspan="1" colspan="1">0.094<xref rid="table-fn5" ref-type="table-fn"><sup>2</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="table-fn3"><p>WFA, weight for age; WFH, weight for height; BMI, body mass index; MUAC, mid-upper arm circumference; TSFT, triceps skinfold thickness.</p></fn><fn id="table-fn3a"><p>Values in bold indicate statistical significance (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></fn><fn id="table-fn4"><label>
<sup>1</sup>
</label><p>Friedman test, pairwise comparisons with Bonferroni correction (significance: <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.016).</p></fn><fn id="table-fn5"><label>
<sup>2</sup>
</label><p>Wilcoxon test.</p></fn><fn id="table-fn6"><label>
<sup>3</sup>
</label><p>Paired samples test (for baseline vs. 6th month).</p></fn><fn id="table-fn7"><p>*<italic>p</italic>&#x02009;=&#x02009;0.012. **<italic>p</italic>&#x02009;=&#x02009;0.005. ***<italic>p</italic>&#x02009;=&#x02009;0.003 compared to baseline.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F1"><label>Figure 1</label><caption><p>Change in anthropometric <italic>z</italic> scores during study visits. When compared to baseline scores, significant improvement was noted in median (min/max) MUAC <italic>z</italic> scores [&#x02212;1.14(&#x02212;2.68/&#x02212;0.19) vs. &#x02212;1.07(&#x02212;2.07/0.32), <italic>p</italic>&#x02009;=&#x02009;0.012], TSFT <italic>z</italic> scores [&#x02212;0.52 (&#x02212;1.29/0.40) vs. &#x02212;0.37(&#x02212;1.05/0.92), <italic>p</italic>&#x02009;=&#x02009;0.005] and WFH <italic>z</italic> scores [&#x02212;2.0 (&#x02212;3.40/&#x02212;0.36) vs. &#x02212;1.52 (&#x02212;3.11/&#x02212;0.35), <italic>p</italic>&#x02009;=&#x02009;0.003] at 6th month visit.</p></caption><graphic xlink:href="fped-13-1448507-g001" position="float"/></fig></sec><sec id="s3d"><title>WFA and WFH <italic>z</italic> scores according to CP subgroups and baseline gastrointestinal symptoms</title><p>When analyzed with respect to clinical classification, WFA <italic>z</italic> scores in children with mixed CP [&#x02212;1.14 (&#x02212;6.85/1.16) vs. &#x02212;1.04 (&#x02212;5.77/0.94), <italic>p</italic>&#x02009;=&#x02009;0.037] and WFH <italic>z</italic> scores in those with spastic CP [&#x02212;2.14 (&#x02212;7.03/2.9) vs. &#x02212;1.64 (&#x02212;7/3.37), <italic>p</italic>&#x02009;=&#x02009;0.002] were significantly improved at 6th month compared to baseline (<xref rid="T4" ref-type="table">Table&#x000a0;4</xref>).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>WFA and WFH <italic>z</italic> scores according to CP classification and baseline gastrointestinal symptoms in children with CP who received a specialized peptide-based enteral formula.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="3" colspan="2"/><th valign="top" align="center" colspan="4" rowspan="1">WFA <italic>z</italic> score</th><th valign="top" align="center" colspan="4" rowspan="1">WFH <italic>z</italic> score</th></tr><tr><th valign="top" align="center" rowspan="2" colspan="1">
<italic>n</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">Baseline</th><th valign="top" align="center" rowspan="1" colspan="1">6th month</th><th valign="top" align="center" rowspan="2" colspan="1">
<italic>p</italic>
</th><th valign="top" align="center" rowspan="2" colspan="1">
<italic>n</italic>
</th><th valign="top" align="center" rowspan="1" colspan="1">Baseline</th><th valign="top" align="center" rowspan="1" colspan="1">6th month</th><th valign="top" align="center" rowspan="2" colspan="1">
<italic>p</italic>
</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Median (min/max)</th><th valign="top" align="center" rowspan="1" colspan="1">Median (min/max)</th><th valign="top" align="center" rowspan="1" colspan="1">Median (min/max)</th><th valign="top" align="center" rowspan="1" colspan="1">Median (min/max)</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="10" rowspan="1">CP classification</td></tr><tr><td valign="top" align="left" rowspan="3" colspan="1">Clinical classification</td><td valign="top" align="left" rowspan="1" colspan="1">Spastic</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2 (&#x02212;6.5/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.17 (&#x02212;6.48/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.417</td><td valign="top" align="center" rowspan="1" colspan="1">67</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.14 (&#x02212;7.03/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.64 (&#x02212;7/3.37)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>002</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Extrapyramidal</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 (&#x02212;3.61/&#x02212;0.3)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.95 (&#x02212;3.89/0.35)</td><td valign="top" align="center" rowspan="1" colspan="1">0.599</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">0.04 (&#x02212;1.43/0.64)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.18 (&#x02212;4/0.88)</td><td valign="top" align="center" rowspan="1" colspan="1">0.230</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mixed</td><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.14 (&#x02212;6.85/1.16)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.04 (&#x02212;5.77/0.94)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>037</bold></td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.81 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.23 (&#x02212;5.61/3.56)</td><td valign="top" align="center" rowspan="1" colspan="1">0.173</td></tr><tr><td valign="top" align="left" rowspan="4" colspan="1">Functional classification</td><td valign="top" align="left" rowspan="1" colspan="1">No activity limitation</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.76 (&#x02212;6.85/&#x02212;0.8)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.16 (&#x02212;5.77/&#x02212;0.64)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>009</bold></td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 (&#x02212;7.4/1.68)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.15 (&#x02212;5.61/1.69)</td><td valign="top" align="center" rowspan="1" colspan="1">0.339</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mild activity limitation</td><td valign="top" align="left" rowspan="1" colspan="1">28</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.8 (&#x02212;5.61/1.77)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.09 (&#x02212;6.13/2.19)</td><td valign="top" align="center" rowspan="1" colspan="1">0.263</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.67 (&#x02212;5.48/0.97)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.55 (&#x02212;5.74/2.13)</td><td valign="top" align="center" rowspan="1" colspan="1">0.512</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Severe activity limitation</td><td valign="top" align="left" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.72 (&#x02212;6.22/1.86)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.9 (&#x02212;6.48/1.88)</td><td valign="top" align="center" rowspan="1" colspan="1">0.226</td><td valign="top" align="center" rowspan="1" colspan="1">28</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.25 (&#x02212;7.03/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.6 (&#x02212;7/3.56)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>020</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No functional activity</td><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.43 (&#x02212;6.5/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.98 (&#x02212;6.34/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.723</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.2 (&#x02212;5.67/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.86 (&#x02212;5.49/3.37)</td><td valign="top" align="center" rowspan="1" colspan="1">0.272</td></tr><tr><td valign="top" align="left" colspan="10" rowspan="1">Initial gastrointestinal symptoms</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Reflux/regurgitation</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.39 (&#x02212;6.85/1.86)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 (&#x02212;5.77/2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">0.827</td><td valign="top" align="center" rowspan="1" colspan="1">54</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.12 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.69 (&#x02212;6.98/3.56)</td><td valign="top" align="center" rowspan="2" colspan="1">0.576</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">31</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.86 (&#x02212;6.5/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.17 (&#x02212;6.48/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">35</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.67 (&#x02212;6.98/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.22 (&#x02212;7/3.19)</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Stomachache</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.82 (&#x02212;6.85/1.16)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.03 (&#x02212;5.77/2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">0.682</td><td valign="top" align="center" rowspan="1" colspan="1">35</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.02 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.66 (&#x02212;5.61/3.56)</td><td valign="top" align="center" rowspan="2" colspan="1">0.488</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.77 (&#x02212;6.5/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.17 (&#x02212;6.34/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">26</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.68 (&#x02212;7.03/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.38 (&#x02212;6.98/3.19)</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Discomfort</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">27</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.27 (&#x02212;6.85/1.86)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.28 (&#x02212;6.48/2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">0.740</td><td valign="top" align="center" rowspan="1" colspan="1">31</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.98 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.66 (&#x02212;7/3.56)</td><td valign="top" align="center" rowspan="2" colspan="1">0.465</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">51</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2 (&#x02212;6.5/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.17 (&#x02212;6.34/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">59</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 (&#x02212;7.03/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.36 (&#x02212;6.98/3.19)</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Nausea</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.39 (&#x02212;6.85/1.86)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.12 (&#x02212;5.77/2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">0.872</td><td valign="top" align="center" rowspan="1" colspan="1">39</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.9 (&#x02212;6.98/3.56)</td><td valign="top" align="center" rowspan="2" colspan="1">0.484</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">39</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.88 (&#x02212;6.5/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.17 (&#x02212;6.48/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">44</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.96 (&#x02212;6.98/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.23 (&#x02212;7/3.19)</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Retching</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.71 (&#x02212;6.85/1.86)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 (&#x02212;6.48/2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">0.939</td><td valign="top" align="center" rowspan="1" colspan="1">38</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.01 (&#x02212;7/3.56)</td><td valign="top" align="center" rowspan="2" colspan="1">0.619</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">44</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.84 (&#x02212;6.5/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.17 (&#x02212;6.34/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">52</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.97 (&#x02212;7.03/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.23 (&#x02212;6.98/3.19)</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Vomiting</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">53</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.27 (&#x02212;6.85/1.86)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.06 (&#x02212;6.48/2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">0.858</td><td valign="top" align="center" rowspan="1" colspan="1">60</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.12 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.62 (&#x02212;7/3.56)</td><td valign="top" align="center" rowspan="2" colspan="1">0.388</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.88 (&#x02212;5.61/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.17 (&#x02212;6.13/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.89 (&#x02212;5.54/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.26 (&#x02212;5.38/3.19)</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Abdominal distension</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">50</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.39 (&#x02212;6.5/1.86)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.54 (&#x02212;6.48/2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">0.127</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 (&#x02212;7.03/1.91)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.9 (&#x02212;7/3.37)</td><td valign="top" align="center" rowspan="2" colspan="1">0.086</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">27</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.79 (&#x02212;5.06/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.7 (&#x02212;4.95/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">31</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.87 (&#x02212;5.06/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.15 (&#x02212;5.38/3.56)</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Diarrhea</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">67</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.88 (&#x02212;6.85/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.17 (&#x02212;6.48/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.815</td><td valign="top" align="center" rowspan="1" colspan="1">77</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.1 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.64 (&#x02212;7/3.56)</td><td valign="top" align="center" rowspan="2" colspan="1">0.772</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.58 (&#x02212;5.36/0.35)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.33 (&#x02212;4.04/0.73)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">13</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.32 (&#x02212;5.38/0.7)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.81 (&#x02212;4/1.8)</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Constipation</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">32</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.8 (&#x02212;6.85/1.86)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.71 (&#x02212;5.77/2.19)</td><td valign="top" align="center" rowspan="1" colspan="1">0.110</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.36 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.65 (&#x02212;5.61/3.56)</td><td valign="top" align="center" rowspan="2" colspan="1">0.053</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.58 (&#x02212;6.5/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.54 (&#x02212;6.48/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">56</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.12 (&#x02212;7.03/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.78 (&#x02212;7/3.37)</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Gas</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2 (&#x02212;6.85/1.86)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.33 (&#x02212;6.48/2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">0.789</td><td valign="top" align="center" rowspan="1" colspan="1">44</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.08 (&#x02212;7.4/3.23)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.4 (&#x02212;7/3.56)</td><td valign="top" align="center" rowspan="2" colspan="1">0.951</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">37</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.12 (&#x02212;5.92/2.32)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.06 (&#x02212;5.54/2.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">45</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.96 (&#x02212;7.03/2.9)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.57 (&#x02212;6.98/3.19)</td></tr></tbody></table><table-wrap-foot><fn id="table-fn8"><p>Repeated measures.</p></fn><fn id="table-fn8a"><p>Values in bold indicate statistical significance (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></fn></table-wrap-foot></table-wrap><p>When analyzed with respect to functional classification, WFA <italic>z</italic> scores in children with no activity limitation [&#x02212;2.76 (&#x02212;6.85/&#x02212;0.8) vs. &#x02212;2.16 (&#x02212;5.77/&#x02212;0.64), <italic>p</italic>&#x02009;=&#x02009;0.009] and WFH <italic>z</italic> scores in those with severe activity limitation [&#x02212;2.25 (&#x02212;7.03/3.23) vs. &#x02212;1.6 (&#x02212;7/3.56), <italic>p</italic>&#x02009;=&#x02009;0.020] were significantly improved at 6th month compared to baseline (<xref rid="T4" ref-type="table">Table&#x000a0;4</xref>).</p><p>No significant change was noted in WFA and WFH <italic>z</italic> scores with respect to type of initial individual gastrointestinal symptoms (<xref rid="T4" ref-type="table">Table&#x000a0;4</xref>).</p></sec><sec id="s3e"><title>Gastrointestinal intolerance symptoms during study visits</title><p>Overall, the rate of &#x0201c;severe (score 4&#x02013;5) symptoms&#x0201d; were significantly decreased, while the rate of &#x0201c;no or mild symptoms&#x0201d; were significantly increased from baseline to 1st month (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for each), 3rd month (<italic>p</italic> values ranged 0.002 to &#x0003c;0.001) and 6th month (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for each). The improvement (increase in those with no or mild degree symptoms) from baseline was particularly remarkable for discomfort (43.8&#x02013;86.5%), retching (56.3&#x02013;87.5%) and abdominal distension (71.9&#x02013;96.9%) symptoms (<xref rid="T5" ref-type="table">Table&#x000a0;5</xref>, <xref rid="F2" ref-type="fig">Figure&#x000a0;2</xref>).</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Gastrointestinal intolerance symptom severity and frequency in children with CP who received a specialized peptide-based enteral formula.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="2" colspan="2">Gastrointestinal symptom severity, <italic>n</italic> (%)</th><th valign="top" align="center" rowspan="2" colspan="1">Baseline A</th><th valign="top" align="center" rowspan="2" colspan="1">1st month B</th><th valign="top" align="center" rowspan="2" colspan="1">3rd month C</th><th valign="top" align="center" rowspan="2" colspan="1">6th month D</th><th valign="top" align="center" colspan="6" rowspan="1"><italic>p</italic> value</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Total</th><th valign="top" align="center" rowspan="1" colspan="1">B vs. A</th><th valign="top" align="center" rowspan="1" colspan="1">C vs. A</th><th valign="top" align="center" rowspan="1" colspan="1">D vs. A</th><th valign="top" align="center" rowspan="1" colspan="1">B vs. C</th><th valign="top" align="center" rowspan="1" colspan="1">D vs. C</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="3" colspan="1">Discomfort</td><td valign="top" rowspan="1" colspan="1">Score 1&#x02013;2 (none-mild)</td><td valign="top" align="center" rowspan="1" colspan="1">42 (43.8)</td><td valign="top" align="center" rowspan="1" colspan="1">81 (84.4)</td><td valign="top" align="center" rowspan="1" colspan="1">78 (81.3)</td><td valign="top" align="center" rowspan="1" colspan="1">83 (86.5)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Score 3 (moderate)</td><td valign="top" rowspan="1" colspan="1">31 (32.3)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (10.4)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.4)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.3)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.387</td><td valign="top" align="center" rowspan="1" colspan="1">0.414</td></tr><tr><td valign="top" rowspan="1" colspan="1">Score 4&#x02013;5 (severe)</td><td valign="top" rowspan="1" colspan="1">23 (24.0)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5.2)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.4)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Reflux/Regurgitation</td><td valign="top" rowspan="1" colspan="1">Score 1&#x02013;2 (none- mild)</td><td valign="top" align="center" rowspan="1" colspan="1">67 (69.8)</td><td valign="top" align="center" rowspan="1" colspan="1">85 (88.5)</td><td valign="top" align="center" rowspan="1" colspan="1">86 (89.6)</td><td valign="top" align="center" rowspan="1" colspan="1">89 (92.7)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Score 3 (moderate)</td><td valign="top" rowspan="1" colspan="1">14 (14.6)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.3)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.501</td><td valign="top" align="center" rowspan="1" colspan="1">0.802</td></tr><tr><td valign="top" rowspan="1" colspan="1">Score 4&#x02013;5 (severe)</td><td valign="top" rowspan="1" colspan="1">15 (15.6)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.1)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Stomachache</td><td valign="top" rowspan="1" colspan="1">Score 1&#x02013;2 (none- mild)</td><td valign="top" align="center" rowspan="1" colspan="1">66 (70.2)</td><td valign="top" align="center" rowspan="1" colspan="1">91 (94.8)</td><td valign="top" align="center" rowspan="1" colspan="1">88 (92.6)</td><td valign="top" align="center" rowspan="1" colspan="1">84 (90.3)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Score 3 (moderate)</td><td valign="top" rowspan="1" colspan="1">14 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.2)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.5)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.968</td><td valign="top" align="center" rowspan="1" colspan="1">0.941</td></tr><tr><td valign="top" rowspan="1" colspan="1">Score 4&#x02013;5 (severe)</td><td valign="top" rowspan="1" colspan="1">14 (14.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.2)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Nausea</td><td valign="top" rowspan="1" colspan="1">Score 1&#x02013;2 (none-mild)</td><td valign="top" align="center" rowspan="1" colspan="1">61 (63.5)</td><td valign="top" align="center" rowspan="1" colspan="1">81 (84.4)</td><td valign="top" align="center" rowspan="1" colspan="1">83 (86.5)</td><td valign="top" align="center" rowspan="1" colspan="1">83 (87.4)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Score 3 (moderate)</td><td valign="top" rowspan="1" colspan="1">15 (15.6)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (10.4)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.3)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (10.5)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.347</td><td valign="top" align="center" rowspan="1" colspan="1">0.822</td></tr><tr><td valign="top" rowspan="1" colspan="1">Score 4&#x02013;5 (severe)</td><td valign="top" rowspan="1" colspan="1">20 (20.8)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5.2)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5.2)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Abdominal Distension</td><td valign="top" rowspan="1" colspan="1">Score 1&#x02013;2 (none- mild)</td><td valign="top" align="center" rowspan="1" colspan="1">69 (71.9)</td><td valign="top" align="center" rowspan="1" colspan="1">93 (96.9)</td><td valign="top" align="center" rowspan="1" colspan="1">85 (88.5)</td><td valign="top" align="center" rowspan="1" colspan="1">93 (96.9)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Score 3 (moderate)</td><td valign="top" rowspan="1" colspan="1">13 (13.5)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.4)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.1)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.041</td><td valign="top" align="center" rowspan="1" colspan="1">0.134</td></tr><tr><td valign="top" rowspan="1" colspan="1">Score 4&#x02013;5 (severe)</td><td valign="top" rowspan="1" colspan="1">14 (14.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Vomiting</td><td valign="top" rowspan="1" colspan="1">Score 1&#x02013;2 (none- mild)</td><td valign="top" align="center" rowspan="1" colspan="1">71 (74)</td><td valign="top" align="center" rowspan="1" colspan="1">88 (91.7)</td><td valign="top" align="center" rowspan="1" colspan="1">86 (90.5)</td><td valign="top" align="center" rowspan="1" colspan="1">90 (93.8)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Score 3 (moderate)</td><td valign="top" rowspan="1" colspan="1">13 (13.5)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.429</td><td valign="top" align="center" rowspan="1" colspan="1">0.313</td></tr><tr><td valign="top" rowspan="1" colspan="1">Score 4&#x02013;5 (severe)</td><td valign="top" rowspan="1" colspan="1">12 (12.5)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.2)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Gas</td><td valign="top" rowspan="1" colspan="1">Score 1&#x02013;2 (none- mild)</td><td valign="top" align="center" rowspan="1" colspan="1">55 (57.9)</td><td valign="top" align="center" rowspan="1" colspan="1">80 (83.3)</td><td valign="top" align="center" rowspan="1" colspan="1">67 (70.5)</td><td valign="top" align="center" rowspan="1" colspan="1">76 (79.2)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Score 3 (moderate)</td><td valign="top" rowspan="1" colspan="1">15 (15.8)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (10.4)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (18.9)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (11.5)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>002</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.032</td><td valign="top" align="center" rowspan="1" colspan="1">0.233</td></tr><tr><td valign="top" rowspan="1" colspan="1">Score 4&#x02013;5 (severe)</td><td valign="top" rowspan="1" colspan="1">25 (26.3)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (10.5)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.4)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Retching</td><td valign="top" rowspan="1" colspan="1">Score 1&#x02013;2 (none- mild)</td><td valign="top" align="center" rowspan="1" colspan="1">54 (56.3)</td><td valign="top" align="center" rowspan="1" colspan="1">78 (81.3)</td><td valign="top" align="center" rowspan="1" colspan="1">76 (79.2)</td><td valign="top" align="center" rowspan="1" colspan="1">84 (87.5)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Score 3 (moderate)</td><td valign="top" rowspan="1" colspan="1">15 (15.6)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (15.6)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (16.7)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.3)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.594</td><td valign="top" align="center" rowspan="1" colspan="1">0.211</td></tr><tr><td valign="top" rowspan="1" colspan="1">Score 4&#x02013;5 (severe)</td><td valign="top" rowspan="1" colspan="1">27 (28.1)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.1)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.2)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><th valign="top" rowspan="2" colspan="2">Gastrointestinal symptom frequency, <italic>n</italic> (%)</th><th valign="top" align="center" rowspan="2" colspan="1">Baseline A</th><th valign="top" align="center" rowspan="2" colspan="1">1st month B</th><th valign="top" align="center" rowspan="2" colspan="1">3rd month C</th><th valign="top" align="center" rowspan="2" colspan="1">6th month D</th><th valign="top" align="center" colspan="6" rowspan="1"><italic>p</italic> value</th></tr><tr><th valign="top" rowspan="1" colspan="1">Total</th><th valign="top" rowspan="1" colspan="1">B vs. A</th><th valign="top" align="center" rowspan="1" colspan="1">C vs. A</th><th valign="top" align="center" rowspan="1" colspan="1">D vs. A</th><th valign="top" align="center" rowspan="1" colspan="1">B vs. C</th><th valign="top" align="center" rowspan="1" colspan="1">D vs. C</th></tr><tr><td valign="top" rowspan="3" colspan="1">Discomfort</td><td valign="top" rowspan="1" colspan="1">None-once a month</td><td valign="top" align="center" rowspan="1" colspan="1">30 (32.6)</td><td valign="top" align="center" rowspan="1" colspan="1">70 (76.1)</td><td valign="top" align="center" rowspan="1" colspan="1">70 (76.1)</td><td valign="top" align="center" rowspan="1" colspan="1">72 (78.3)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">On a weekly basis</td><td valign="top" rowspan="1" colspan="1">36 (39.1)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (16.3)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (14.1)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (13)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.388</td><td valign="top" align="center" rowspan="1" colspan="1">0.376</td></tr><tr><td valign="top" rowspan="1" colspan="1">Ona daily basis</td><td valign="top" rowspan="1" colspan="1">26 (28.3)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.6)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.8)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.7)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Reflux/Regurgitation</td><td valign="top" rowspan="1" colspan="1">None-once a month</td><td valign="top" align="center" rowspan="1" colspan="1">63 (68.5)</td><td valign="top" align="center" rowspan="1" colspan="1">74 (80.4)</td><td valign="top" align="center" rowspan="1" colspan="1">78 (84.8)</td><td valign="top" align="center" rowspan="1" colspan="1">78 (84.8)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">On a weekly basis</td><td valign="top" rowspan="1" colspan="1">14 (15.2)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (13)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (10.9)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.235</td><td valign="top" align="center" rowspan="1" colspan="1">0.571</td></tr><tr><td valign="top" rowspan="1" colspan="1">Ona daily basis</td><td valign="top" rowspan="1" colspan="1">15 (16.3)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.6)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.3)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Stomachache</td><td valign="top" rowspan="1" colspan="1">None-once a month</td><td valign="top" align="center" rowspan="1" colspan="1">59 (65.6)</td><td valign="top" align="center" rowspan="1" colspan="1">80 (88.9)</td><td valign="top" align="center" rowspan="1" colspan="1">83 (92.3)</td><td valign="top" align="center" rowspan="1" colspan="1">80 (88.9)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">On a weekly basis</td><td valign="top" rowspan="1" colspan="1">23 (25.5)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.9)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.4)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.8)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.531</td><td valign="top" align="center" rowspan="1" colspan="1">0.587</td></tr><tr><td valign="top" rowspan="1" colspan="1">Ona daily basis</td><td valign="top" rowspan="1" colspan="1">8 (8.9)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.3)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.3)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Nausea</td><td valign="top" rowspan="1" colspan="1">None-once a month</td><td valign="top" align="center" rowspan="1" colspan="1">50 (54.3)</td><td valign="top" align="center" rowspan="1" colspan="1">69 (75)</td><td valign="top" align="center" rowspan="1" colspan="1">72 (78.3)</td><td valign="top" align="center" rowspan="1" colspan="1">71 (77.2)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">On a weekly basis</td><td valign="top" rowspan="1" colspan="1">19 (20.7)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (17.4)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (15.2)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (17.4)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.471</td><td valign="top" align="center" rowspan="1" colspan="1">0.758</td></tr><tr><td valign="top" rowspan="1" colspan="1">Ona daily basis</td><td valign="top" rowspan="1" colspan="1">23 (25)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.6)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.5)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5.4)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Abdominal Distension</td><td valign="top" rowspan="1" colspan="1">None-once a month</td><td valign="top" align="center" rowspan="1" colspan="1">64 (70.3)</td><td valign="top" align="center" rowspan="1" colspan="1">86 (94.5)</td><td valign="top" align="center" rowspan="1" colspan="1">82 (90.1)</td><td valign="top" align="center" rowspan="1" colspan="1">83 (91.2)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">On a weekly basis</td><td valign="top" rowspan="1" colspan="1">19 (20.9)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.3)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.8)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.7)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.330</td><td valign="top" align="center" rowspan="1" colspan="1">0.792</td></tr><tr><td valign="top" rowspan="1" colspan="1">Ona daily basis</td><td valign="top" rowspan="1" colspan="1">8 (8.8)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.1)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.1)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Vomiting</td><td valign="top" rowspan="1" colspan="1">None-once a month</td><td valign="top" align="center" rowspan="1" colspan="1">64 (71.1)</td><td valign="top" align="center" rowspan="1" colspan="1">79 (87.8)</td><td valign="top" align="center" rowspan="1" colspan="1">77 (85.6)</td><td valign="top" align="center" rowspan="1" colspan="1">79 (87.8)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">On a weekly basis</td><td valign="top" rowspan="1" colspan="1">16 (17.8)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.8)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (10)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.9)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>003</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>002</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.720</td><td valign="top" align="center" rowspan="1" colspan="1">0.397</td></tr><tr><td valign="top" rowspan="1" colspan="1">Ona daily basis</td><td valign="top" rowspan="1" colspan="1">10 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.4)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.4)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.3)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Gas</td><td valign="top" rowspan="1" colspan="1">None-once a month</td><td valign="top" align="center" rowspan="1" colspan="1">45 (49.4)</td><td valign="top" align="center" rowspan="1" colspan="1">63 (69.2)</td><td valign="top" align="center" rowspan="1" colspan="1">62 (68.1)</td><td valign="top" align="center" rowspan="1" colspan="1">62 (68.1)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">On a weekly basis</td><td valign="top" rowspan="1" colspan="1">24 (26.4)</td><td valign="top" align="center" rowspan="1" colspan="1">17 (18.7)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (17.6)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (20.9)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>002</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.333</td><td valign="top" align="center" rowspan="1" colspan="1">0.749</td></tr><tr><td valign="top" rowspan="1" colspan="1">Ona daily basis</td><td valign="top" rowspan="1" colspan="1">22 (24.2)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (12.1)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (14.3)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (11)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="3" colspan="1">Retching</td><td valign="top" rowspan="1" colspan="1">None-once a month</td><td valign="top" align="center" rowspan="1" colspan="1">43 (46.2)</td><td valign="top" align="center" rowspan="1" colspan="1">64 (68.8)</td><td valign="top" align="center" rowspan="1" colspan="1">70 (75.3)</td><td valign="top" align="center" rowspan="1" colspan="1">72 (77.4)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">On a weekly basis</td><td valign="top" rowspan="1" colspan="1">27 (29.1)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (21.5)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (17.2)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (14)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.560</td><td valign="top" align="center" rowspan="1" colspan="1">0.508</td></tr><tr><td valign="top" rowspan="1" colspan="1">Ona daily basis</td><td valign="top" rowspan="1" colspan="1">23 (24.7)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.7)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.5)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="table-fn9"><p>Gastrointestinal symptom frequency scores of &#x0201c;1 to 6&#x0201d; were re-grouped to include none-once a month (score 1 and 2), on a weekly basis (score 3 and 4) and on a daily basis (score 5 and 6) groups.</p></fn><fn id="table-fn9a"><p>Values in bold indicate statistical significance (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></fn><fn id="table-fn10"><p>Friedman test and Wilcoxon test for pairwise comparisons (significance: <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.008 after Bonferroni correction).</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F2"><label>Figure 2</label><caption><p>Change in gastrointestinal symptom severity during study visits. Overall, the rate of &#x0201c;severe (score 4&#x02212;5) symptoms&#x0201d; were significantly decreased, while the rate of &#x0201c;no or mild symptoms&#x0201d; were significantly increased from baseline to 1st month (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for each), 3rd month (<italic>p</italic> values ranged 0.002 to &#x0003c;0.001) and 6th month (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for each).</p></caption><graphic xlink:href="fped-13-1448507-g002" position="float"/></fig><p>The percentage of children who experience symptoms on a daily basis significantly decreased along with significant increase in the percentage of children with no or once monthly symptoms baseline to 1st month (<italic>p</italic> values ranged 0.001 to &#x0003c;0.001 for each), 3rd month (<italic>p</italic> values ranged 0.003 to &#x0003c;0.001) and 6th month (<italic>p</italic> values ranged 0.002 to &#x0003c;0.001). In general, improvement in frequency occurred within one month and was sustained through 6 months with increase in the percentage of children with lesser symptom frequency to &#x0223c;70% or 75% depending on symptom which stayed at that level throughout. The improvement (decrease in those who experience symptoms on a daily basis) from baseline was particularly remarkable for discomfort (28.3 to 8.7%), nausea (25.0 to 5.4%), retching (24.7 to 8.6%) and gas (24.2 to 11.0%) symptoms (<xref rid="T5" ref-type="table">Table&#x000a0;5</xref>, <xref rid="F3" ref-type="fig">Figure&#x000a0;3</xref>).</p><fig position="float" id="F3"><label>Figure 3</label><caption><p>Change in gastrointestinal symptom frequency during study visits. The percentage of children who experience symptoms on a daily basis significantly decreased along with significant increase in the percentage of children with no or once monthly symptoms baseline to 1st month (<italic>p</italic> values ranged 0.001 to &#x0003c;0.001 for each), 3rd month (<italic>p</italic> values ranged 0.003 to &#x0003c;0.001) and 6th month (<italic>p</italic> values ranged 0.002 to &#x0003c;0.001).</p></caption><graphic xlink:href="fped-13-1448507-g003" position="float"/></fig></sec><sec id="s3f"><title>Defecation frequency and stool patterns during study visits</title><p>When compared to baseline, 1st month, 3rd month and 6th month assessments revealed significant decrease in the likelihood of Type-1/Type-2 (constipation) stool pattern (from 31.6% at baseline to 7.4%, 2.1% and 3.2%, respectively, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for each) (<xref rid="T6" ref-type="table">Table&#x000a0;6</xref>).</p><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>Defecation frequency and stool patterns in children with CP who received a specialized peptide-based enteral formula.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="2" colspan="1"/><th valign="top" align="center" rowspan="2" colspan="1">Baseline A</th><th valign="top" align="center" rowspan="2" colspan="1">1st month B</th><th valign="top" align="center" rowspan="2" colspan="1">3rd month C</th><th valign="top" align="center" rowspan="2" colspan="1">6th month D</th><th valign="top" align="center" colspan="7" rowspan="1"><italic>p</italic> value</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Total</th><th valign="top" align="center" rowspan="1" colspan="1">B vs. A</th><th valign="top" align="center" rowspan="1" colspan="1">C vs. A</th><th valign="top" align="center" rowspan="1" colspan="1">D vs. A</th><th valign="top" align="center" rowspan="1" colspan="1">C vs. B</th><th valign="top" align="center" rowspan="1" colspan="1">D vs. B</th><th valign="top" align="center" rowspan="1" colspan="1">C vs. D</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="12" rowspan="1">Stool pattern, <italic>n</italic> (%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Type-1/Type-2 <italic>(constipation)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">30 (31.6)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.1)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.2)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Type-3/Type-4 <italic>(normal)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">27 (28.4)</td><td valign="top" align="center" rowspan="1" colspan="1">34 (35.8)</td><td valign="top" align="center" rowspan="1" colspan="1">34 (35.8)</td><td valign="top" align="center" rowspan="1" colspan="1">35 (36.8)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.102</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">0.513</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Type-5/Type-6/Type-7 <italic>(diarrhea)</italic></td><td valign="top" align="center" rowspan="1" colspan="1">38 (40.0)</td><td valign="top" align="center" rowspan="1" colspan="1">54 (56.8)</td><td valign="top" align="center" rowspan="1" colspan="1">59 (62.1)</td><td valign="top" align="center" rowspan="1" colspan="1">57 (60.0)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="12" rowspan="1">Defecation frequency, <italic>n</italic> (%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Once a week or less</td><td valign="top" align="center" rowspan="1" colspan="1">35 (36.5)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.3)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (12.5)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.3)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Once a day/once in every 2&#x02013;3 days</td><td valign="top" align="center" rowspan="1" colspan="1">41 (42.7)</td><td valign="top" align="center" rowspan="1" colspan="1">68 (70.8)</td><td valign="top" align="center" rowspan="1" colspan="1">71 (74)</td><td valign="top" align="center" rowspan="1" colspan="1">74 (77.1)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.049</td><td valign="top" align="center" rowspan="1" colspan="1">0.012</td><td valign="top" align="center" rowspan="1" colspan="1">0.048</td><td valign="top" align="center" rowspan="1" colspan="1">0.273</td><td valign="top" align="center" rowspan="1" colspan="1">0.225</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">At least 2&#x02013;3 times per day</td><td valign="top" align="center" rowspan="1" colspan="1">20 (20.8)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (20.8)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (13.5)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (14.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="12" rowspan="1">Normal defecation frequency<xref rid="table-fn11" ref-type="table-fn"><sup>a</sup></xref> in children with symptoms, <italic>n</italic> (%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Reflux/regurgitation</td><td valign="top" align="center" rowspan="1" colspan="1">17 (44.7)</td><td valign="top" align="center" rowspan="1" colspan="1">27 (71.1)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (73.7)</td><td valign="top" align="center" rowspan="1" colspan="1">29 (76.3)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>008</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.072</td><td valign="top" align="center" rowspan="1" colspan="1">0.019</td><td valign="top" align="center" rowspan="1" colspan="1">0.366</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td><td valign="top" align="center" rowspan="1" colspan="1">0.180</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stomachache</td><td valign="top" align="center" rowspan="1" colspan="1">11 (39.3)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (75.0)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (75)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (67.9)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>007</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>002</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.034</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td><td valign="top" align="center" rowspan="1" colspan="1">0.014</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Discomfort</td><td valign="top" align="center" rowspan="1" colspan="1">29 (46)</td><td valign="top" align="center" rowspan="1" colspan="1">47 (74.6)</td><td valign="top" align="center" rowspan="1" colspan="1">47 (74.6)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (77.8)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.078</td><td valign="top" align="center" rowspan="1" colspan="1">0.010</td><td valign="top" align="center" rowspan="1" colspan="1">0.011</td><td valign="top" align="center" rowspan="1" colspan="1">0.180</td><td valign="top" align="center" rowspan="1" colspan="1">0.058</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nausea</td><td valign="top" align="center" rowspan="1" colspan="1">22 (46.8)</td><td valign="top" align="center" rowspan="1" colspan="1">32 (68.1)</td><td valign="top" align="center" rowspan="1" colspan="1">34 (72.3)</td><td valign="top" align="center" rowspan="1" colspan="1">37 (78.7)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>004</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.041</td><td valign="top" align="center" rowspan="1" colspan="1">0.027</td><td valign="top" align="center" rowspan="1" colspan="1">0.317</td><td valign="top" align="center" rowspan="1" colspan="1">0.439</td><td valign="top" align="center" rowspan="1" colspan="1">0.655</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Retching</td><td valign="top" align="center" rowspan="1" colspan="1">26 (46.4)</td><td valign="top" align="center" rowspan="1" colspan="1">40 (71.4)</td><td valign="top" align="center" rowspan="1" colspan="1">44 (78.6)</td><td valign="top" align="center" rowspan="1" colspan="1">48 (85.7)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>008</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>003</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.051</td><td valign="top" align="center" rowspan="1" colspan="1">0.023</td><td valign="top" align="center" rowspan="1" colspan="1">0.346</td><td valign="top" align="center" rowspan="1" colspan="1">0.617</td><td valign="top" align="center" rowspan="1" colspan="1">0.480</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vomiting</td><td valign="top" align="center" rowspan="1" colspan="1">16 (50)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (71.9)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (75)</td><td valign="top" align="center" rowspan="1" colspan="1">25 (78.1)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>049</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.013</td><td valign="top" align="center" rowspan="1" colspan="1">0.201</td><td valign="top" align="center" rowspan="1" colspan="1">0.050</td><td valign="top" align="center" rowspan="1" colspan="1">0.317</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td><td valign="top" align="center" rowspan="1" colspan="1">0.083</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Abdominal distension</td><td valign="top" align="center" rowspan="1" colspan="1">14 (40)</td><td valign="top" align="center" rowspan="1" colspan="1">25 (71.4)</td><td valign="top" align="center" rowspan="1" colspan="1">25 (71.4)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (80)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.285</td><td valign="top" align="center" rowspan="1" colspan="1">0.763</td><td valign="top" align="center" rowspan="1" colspan="1">0.257</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Residue (for gastrostomy patients)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (70)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (80)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (90)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (90)</td><td valign="top" align="center" rowspan="1" colspan="1">0.190</td><td valign="top" align="center" rowspan="1" colspan="1">0.083</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td><td valign="top" align="center" rowspan="1" colspan="1">0.083</td><td valign="top" align="center" rowspan="1" colspan="1">0.083</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gas</td><td valign="top" align="center" rowspan="1" colspan="1">20 (42.6)</td><td valign="top" align="center" rowspan="1" colspan="1">35 (74.5)</td><td valign="top" align="center" rowspan="1" colspan="1">37 (78.7)</td><td valign="top" align="center" rowspan="1" colspan="1">36 (76.6)</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>003</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold>.<bold>001</bold></td><td valign="top" align="center" rowspan="1" colspan="1">0.059</td><td valign="top" align="center" rowspan="1" colspan="1">0.197</td><td valign="top" align="center" rowspan="1" colspan="1">0.180</td></tr></tbody></table><table-wrap-foot><fn id="table-fn12a"><p>Values in bold indicate statistical significance (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></fn><fn id="table-fn12"><p>Friedman test and Wilcoxon test for pairwise comparisons (significance: <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.008 after Bonferroni correction).</p></fn><fn id="table-fn11"><label>
<sup>a</sup>
</label><p>Once a day/once in every 2&#x02013;3 days.</p></fn></table-wrap-foot></table-wrap><p>The rate of normal (once a day or in every 2&#x02013;3 days) defecation frequency was also increased from 42.7% at baseline to 70.8% at 1st month (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) and this increase was maintained at 3rd and 6th month visits, particularly in the presence of stomachache (from 39.3 to 75% at 3rd month, <italic>p</italic>&#x02009;=&#x02009;0.007 and to 67.9% at 6th month, <italic>p</italic>&#x02009;=&#x02009;0.002), abdominal distension (from 40.0 to 71.4% and 80.0%, <italic>p</italic>&#x02009;=&#x02009;0.001 and <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, respectively) and gas (from 42.6 to 78.7% and 76.6%, <italic>p</italic>&#x02009;=&#x02009;0.003 and <italic>p</italic>&#x02009;=&#x02009;0.001, respectively) (<xref rid="T6" ref-type="table">Table&#x000a0;6</xref>).</p></sec><sec id="s3g"><title>Parent assessment on feeding and stool patterns</title><p>Most of parents reported that peptide-based enteral formula was associated with normalization of bowel movements (&#x0003e;85%) via decreasing the likelihood of increased bowel movements (&#x0003e;68%) as well as the constipation (&#x0003e;76%), with no vomiting after feeding (&#x0003e;82%) and an improved general status of the child (&#x0003e;79%), regardless of the follow up visit (<xref rid="T7" ref-type="table">Table&#x000a0;7</xref>).</p><table-wrap position="float" id="T7"><label>Table 7</label><caption><p>Parent assessment on feeding and stool patterns and parental satisfaction with the nutritional product in children with CP.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" colspan="2" rowspan="1">Parental satisfaction&#x02014;Formula Satisfaction Questionnaire, <italic>n</italic> (%)</th><th valign="top" align="center" rowspan="1" colspan="1">1st month</th><th valign="top" align="center" rowspan="1" colspan="1">3rd month</th><th valign="top" align="center" rowspan="1" colspan="1">6th month</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="3" colspan="1">How satisfied were you with the nutritional product overall?</td><td valign="top" rowspan="1" colspan="1">Satisfied</td><td valign="top" align="center" rowspan="1" colspan="1">72 (79.1)</td><td valign="top" align="center" rowspan="1" colspan="1">76 (80)</td><td valign="top" align="center" rowspan="1" colspan="1">84 (90.3)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Moderately satisfied</td><td valign="top" rowspan="1" colspan="1">17 (18.7)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (18.9)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Not satisfied</td><td valign="top" rowspan="1" colspan="1">2 (2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.1)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td valign="top" rowspan="3" colspan="1">Would you like to continue using the nutritional product?</td><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">83 (91.2)</td><td valign="top" align="center" rowspan="1" colspan="1">86 (90.5)</td><td valign="top" align="center" rowspan="1" colspan="1">88 (94.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Maybe</td><td valign="top" rowspan="1" colspan="1">8 (8.8)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.4)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.2)</td></tr><tr><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" rowspan="1" colspan="1">&#x02014;</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.1)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (2.2)</td></tr><tr><td valign="top" rowspan="7" colspan="1">What is your favorite feature of the nutritional product?</td><td valign="top" rowspan="1" colspan="1">Easily available in pharmacies</td><td valign="top" align="center" rowspan="1" colspan="1">53 (55.2)</td><td valign="top" align="center" rowspan="1" colspan="1">58 (60.4)</td><td valign="top" align="center" rowspan="1" colspan="1">55 (57.3)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Product box/packaging</td><td valign="top" rowspan="1" colspan="1">33 (34.4)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (51.0)</td><td valign="top" align="center" rowspan="1" colspan="1">40 (41.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Ease of use of the product</td><td valign="top" rowspan="1" colspan="1">59 (61.5)</td><td valign="top" align="center" rowspan="1" colspan="1">54 (56.3)</td><td valign="top" align="center" rowspan="1" colspan="1">69 (71.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1">The consistency of the product</td><td valign="top" rowspan="1" colspan="1">36 (37.5)</td><td valign="top" align="center" rowspan="1" colspan="1">52 (54.2)</td><td valign="top" align="center" rowspan="1" colspan="1">46 (47.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1">The smell of the product</td><td valign="top" rowspan="1" colspan="1">33 (34.4)</td><td valign="top" align="center" rowspan="1" colspan="1">37 (38.5)</td><td valign="top" align="center" rowspan="1" colspan="1">42 (43.8)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Nursing service provided</td><td valign="top" rowspan="1" colspan="1">14 (14.6)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (25)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (29.2)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Other</td><td valign="top" rowspan="1" colspan="1">13 (13.5)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (13.5)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (9.4)</td></tr><tr><th valign="top" colspan="2" rowspan="1">Parent assessment on feeding and stool patterns&#x02014;Feeding and Stool Patterns Questionnaire, <italic>n</italic> (%)</th><th valign="top" align="center" rowspan="1" colspan="1">1st month</th><th valign="top" align="center" rowspan="1" colspan="1">3rd month</th><th valign="top" align="center" rowspan="1" colspan="1">6th month</th></tr><tr><td valign="top" rowspan="3" colspan="1">How was your child's general status while using the nutritional product?</td><td valign="top" rowspan="1" colspan="1">Good</td><td valign="top" align="center" rowspan="1" colspan="1">72 (79.1)</td><td valign="top" align="center" rowspan="1" colspan="1">81 (85.3)</td><td valign="top" align="center" rowspan="1" colspan="1">81 (87.1)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Moderate</td><td valign="top" rowspan="1" colspan="1">18 (19.8)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (14.7)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (12.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Poor</td><td valign="top" rowspan="1" colspan="1">1 (1.1)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02014;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td valign="top" rowspan="2" colspan="1">Did your child have any problems while taking the nutritional product?</td><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">89 (97.8)</td><td valign="top" align="center" rowspan="1" colspan="1">89 (93.7)</td><td valign="top" align="center" rowspan="1" colspan="1">88 (94.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" rowspan="1" colspan="1">2 (2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5.4)</td></tr><tr><td valign="top" rowspan="3" colspan="1">My child vomited after feeding</td><td valign="top" rowspan="1" colspan="1">Always Often</td><td valign="top" align="center" rowspan="1" colspan="1">3 (3.3)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.3)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.3)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Sometimes</td><td valign="top" rowspan="1" colspan="1">13 (14.4)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (10.8)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Rarely Never</td><td valign="top" rowspan="1" colspan="1">74 (82.2)</td><td valign="top" align="center" rowspan="1" colspan="1">77 (83.7)</td><td valign="top" align="center" rowspan="1" colspan="1">79 (84.9)</td></tr><tr><td valign="top" rowspan="3" colspan="1">My child's bowel movements are in order</td><td valign="top" rowspan="1" colspan="1">Always Often</td><td valign="top" align="center" rowspan="1" colspan="1">65 (71.4)</td><td valign="top" align="center" rowspan="1" colspan="1">67 (70.5)</td><td valign="top" align="center" rowspan="1" colspan="1">76 (81.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Sometimes</td><td valign="top" rowspan="1" colspan="1">16 (17.6)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (14.7)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (10.8)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Rarely Never</td><td valign="top" rowspan="1" colspan="1">10 (11)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (14.7)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (7.5)</td></tr><tr><td valign="top" rowspan="3" colspan="1">There were days when bowel movements were too much</td><td valign="top" rowspan="1" colspan="1">Always Often</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.7)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (6.4)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Sometimes</td><td valign="top" rowspan="1" colspan="1">15 (16.7)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (21.3)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (22.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Rarely Never</td><td valign="top" rowspan="1" colspan="1">69 (76.7)</td><td valign="top" align="center" rowspan="1" colspan="1">68 (72.3)</td><td valign="top" align="center" rowspan="1" colspan="1">64 (68.8)</td></tr><tr><td valign="top" rowspan="3" colspan="1">My child is constipated</td><td valign="top" rowspan="1" colspan="1">Always Often</td><td valign="top" align="center" rowspan="1" colspan="1">10 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (10.8)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (5.4)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Sometimes</td><td valign="top" rowspan="1" colspan="1">11 (12.2)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.6)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (8.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Rarely Never</td><td valign="top" rowspan="1" colspan="1">69 (76.7)</td><td valign="top" align="center" rowspan="1" colspan="1">75 (80.6)</td><td valign="top" align="center" rowspan="1" colspan="1">80 (86)</td></tr></tbody></table></table-wrap></sec><sec id="s3h"><title>Parent's satisfaction with the nutritional product</title><p>Majority of parents were satisfied with the study formula (97.8% at 1st month visit, 98.9% at 3rd month visit and 100.0% at 6th month visit), reported no problems (97.8%, 93.7% and 94.6%, respectively) and they wished to continue using the enteral formula (91.2%, 90.5% and 94.6%, respectively) (<xref rid="T7" ref-type="table">Table&#x000a0;7</xref>).</p><p>The favorite feature of the product was considered to be ease of use (by 61.5%, 56.3% and 71.9% of parents at 1st, 3rd and 6th month visits, respectively) and its availability in pharmacies (by 55.2%, 60.4% and 57.3% of parents at 1st, 3rd and 6th month visits, respectively) (<xref rid="T7" ref-type="table">Table&#x000a0;7</xref>).</p></sec><sec id="s3i"><title>Laboratory findings and adverse events</title><p>Other than significantly increased percentage of patients with high serum albumin (13.6 vs. 47.5%, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), no significant change was noted in blood analysis findings during follow up visits. In total, 28 adverse events were reported in 22 children during study period, and the most frequently reported AEs were death (<italic>n</italic>&#x02009;=&#x02009;6), pneumonia (<italic>n</italic>&#x02009;=&#x02009;6), discomfort with PEG (<italic>n</italic>&#x02009;=&#x02009;6) and upper respiratory infection (<italic>n</italic>&#x02009;=&#x02009;5) (<xref rid="T8" ref-type="table">Table&#x000a0;8</xref>).</p><table-wrap position="float" id="T8"><label>Table 8</label><caption><p>Laboratory findings and adverse events during nutritional support in children with CP.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">Baseline</th><th valign="top" align="left" rowspan="1" colspan="1">3rd month</th><th valign="top" align="left" rowspan="1" colspan="1">6th month</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>p</italic> value<xref rid="table-fn14" ref-type="table-fn"><sup>1</sup></xref></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="6" rowspan="1">Blood analysis</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Leukocyte (<italic>n</italic>&#x02009;=&#x02009;60), median (min/max)</td><td valign="top" align="center" rowspan="1" colspan="1">8.6 (3/29.7)</td><td valign="top" align="center" rowspan="1" colspan="1">8.2 (2.5/74.6)</td><td valign="top" align="center" rowspan="1" colspan="1">8.3 (3.3/25.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="3" colspan="1"><italic>n</italic> (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">5 (8.3)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (5)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (3.3)</td><td valign="top" align="center" rowspan="3" colspan="1">0.254</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normal</td><td valign="top" align="left" rowspan="1" colspan="1">42 (70)</td><td valign="top" align="center" rowspan="1" colspan="1">50 (83.3)</td><td valign="top" align="center" rowspan="1" colspan="1">45 (75)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High</td><td valign="top" align="left" rowspan="1" colspan="1">13 (21.7)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (11.7)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (21.7)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Hemoglobin (<italic>n</italic>&#x02009;=&#x02009;68), median (min/max)</td><td valign="top" align="center" rowspan="1" colspan="1">12.9 (7.1/16.9)</td><td valign="top" align="center" rowspan="1" colspan="1">13.0 (9.3/16.5)</td><td valign="top" align="center" rowspan="1" colspan="1">13.3 (6.5/15.9)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="3" colspan="1"><italic>n</italic> (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">8 (11.8)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (13.2)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (5.9)</td><td valign="top" align="center" rowspan="3" colspan="1">0.058</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normal</td><td valign="top" align="left" rowspan="1" colspan="1">52 (76.4)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (72.1)</td><td valign="top" align="center" rowspan="1" colspan="1">52 (76.5)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High</td><td valign="top" align="left" rowspan="1" colspan="1">8 (11.8)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (14.7)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (17.6)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Hematocrit (<italic>n</italic>&#x02009;=&#x02009;68), median (min/max)</td><td valign="top" align="center" rowspan="1" colspan="1">38 (23/50)</td><td valign="top" align="center" rowspan="1" colspan="1">38 (4.6/48)</td><td valign="top" align="center" rowspan="1" colspan="1">39 (23/45.9)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="3" colspan="1"><italic>n</italic> (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">7 (10.3)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (4.4)</td><td valign="top" align="center" rowspan="3" colspan="1">0.104</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normal</td><td valign="top" align="left" rowspan="1" colspan="1">57 (83.8)</td><td valign="top" align="center" rowspan="1" colspan="1">54 (79.4)</td><td valign="top" align="center" rowspan="1" colspan="1">59 (86.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High</td><td valign="top" align="left" rowspan="1" colspan="1">4 (5.9)</td><td valign="top" align="center" rowspan="1" colspan="1">9 (13.2)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (8.8)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Serum albumin (<italic>n</italic>&#x02009;=&#x02009;59), median (min/max)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (3.0/6.0)</td><td valign="top" align="center" rowspan="1" colspan="1">4.2 (3/7.3)</td><td valign="top" align="center" rowspan="1" colspan="1">4.3 (3.3/7.5)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="3" colspan="1"><italic>n</italic> (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">3 (5.1)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.7)</td><td valign="top" align="center" rowspan="3" colspan="1"><bold>&#x0003c;0</bold>.<bold>001</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normal</td><td valign="top" align="left" rowspan="1" colspan="1">48 (81.3)</td><td valign="top" align="center" rowspan="1" colspan="1">48 (81.4)</td><td valign="top" align="center" rowspan="1" colspan="1">30 (50.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High</td><td valign="top" align="left" rowspan="1" colspan="1">8 (13.6)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (16.9)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (47.5)</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Total protein (<italic>n</italic>&#x02009;=&#x02009;50), median (min/max)</td><td valign="top" align="center" rowspan="1" colspan="1">6.7 (1.6/8.1)</td><td valign="top" align="center" rowspan="1" colspan="1">6.8 (3.0/8.1)</td><td valign="top" align="center" rowspan="1" colspan="1">7.0 (3.0/8.3)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="3" colspan="1"><italic>n</italic> (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">11 (22)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (10)</td><td valign="top" align="center" rowspan="3" colspan="1">0.156</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normal</td><td valign="top" align="left" rowspan="1" colspan="1">38 (76)</td><td valign="top" align="center" rowspan="1" colspan="1">44 (88)</td><td valign="top" align="center" rowspan="1" colspan="1">43 (86)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High</td><td valign="top" align="left" rowspan="1" colspan="1">1 (2)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02014;</td><td valign="top" align="center" rowspan="1" colspan="1">2 (4)</td></tr><tr><td valign="top" align="left" colspan="1" rowspan="1">Adverse events</td><td valign="top" align="center" colspan="5" rowspan="1"><italic>n</italic> (%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Patients with AEs</td><td valign="top" align="center" colspan="5" rowspan="1">22 (22.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Death</td><td valign="top" align="center" colspan="5" rowspan="1">6 (6.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pneumonia</td><td valign="top" align="center" colspan="5" rowspan="1">6 (6.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Discomfort with the PEG<xref rid="table-fn13" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="center" colspan="5" rowspan="1">6 (6.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Upper respiratory infection</td><td valign="top" align="center" colspan="5" rowspan="1">5 (5.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gastrointestinal bleeding</td><td valign="top" align="center" colspan="5" rowspan="1">1 (1.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Increase in seizures</td><td valign="top" align="center" colspan="5" rowspan="1">1 (1.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sepsis</td><td valign="top" align="center" colspan="5" rowspan="1">1 (1.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Occluded tracheostomy</td><td valign="top" align="center" colspan="5" rowspan="1">1 (1.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Viscous saliva</td><td valign="top" align="center" colspan="5" rowspan="1">1 (1.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total number of AEs</td><td valign="top" align="center" colspan="5" rowspan="1">28<xref rid="table-fn15" ref-type="table-fn"><sup>2</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="table-fn13a"><p>Values in bold indicate statistical significance (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></fn><fn id="table-fn13"><label>
<sup>a</sup>
</label><p>Obstruction, redness, food leakage, increased arrivals, leakage, bleeding.</p></fn><fn id="table-fn14"><label>
<sup>1</sup>
</label><p>Friedman test and pairwise comparisons with the Wilcoxon test (<italic>p</italic>-value after Bonferroni correction: 0.017).</p></fn><fn id="table-fn15"><label>
<sup>2</sup>
</label><p>More than one event occurred in 5 patients.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Our findings revealed that use of a specialized peptide-based formula containing MCT (Pediasure&#x000ae; peptide in majority of cases) in children with CP and feeding intolerance on previous tube feeding with standard enteral formula was associated with improved anthropometrics, amelioration in gastrointestinal intolerance symptoms both in terms of severity and frequency, normalization of defecation frequency and stool patterns and a high parental satisfaction with the formula. In general, improvement in frequency occurred within one month and was sustained through 6 months with increase in the percentage of children with lesser symptom frequency to &#x0223c;70% or 75% depending on symptom which stayed at that level throughout.</p><p>Spastic CP as accompanied with severe or total functional limitation was the leading diagnosis in our study population, while gastrointestinal discomfort, constipation and retching were the most common gastrointestinal intolerance symptoms recorded at baseline. Similarly, in a study among 1,108 children with CP from Turkey, the quadriplegic spastic CP was reported in majority of children in addition to Gross Motor Function Classification System (GMFCS) level V motor dysfunction, co-morbid gastrointestinal problems (constipation, lack of appetite and difficulty in swallowing) and malnutrition, especially in those with higher levels of gross motor dysfunction (<xref rid="B7" ref-type="bibr">7</xref>). Data from the multi-country PURPLE N (Profiling Children and Youth with Cerebral Palsy in Relation to Feeding and Nutrition) study, including Turkey, also revealed the severe form of CP (spastic CP in 84%, quadriplegia in 55%, and GMFCS level VI-V in 50%) along with gastrointestinal problems (i.e., constipation, gastrointestinal reflux, vomiting and retching) in most of children and a higher risk of malnutrition particularly in those with higher GMFCS level (<xref rid="B31" ref-type="bibr">31</xref>).</p><p>In fact, prevalence of malnutrition reported by different studies in children with CP ranges from 40% to 90%, depending on the study population and anthropometric tool (<xref rid="B32" ref-type="bibr">32</xref>&#x02013;<xref rid="B35" ref-type="bibr">35</xref>). Previous multicenter studies in our country also revealed a considerable difference in the prevalence of malnutrition in children with CP, which was reported to be 57.2%, 92.6% to 94.3% and 91.3%, based on physicians' clinical judgment, Gomez classification of WFA percentiles and Waterlow classification of HFA percentiles, respectively (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B36" ref-type="bibr">36</xref>). Hence, use of growth charts for general pediatric population for anthropometric assessment in children with CP is considered to be associated with a risk of overestimating malnutrition in these children (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B37" ref-type="bibr">37</xref>). Indeed, while anthropometric references exist for children with CP, they are not currently recommended because they only allow to know the growth from children with different degrees of severity, not the desirable growth, so the nutritional objective is restricted (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>).</p><p>Nonetheless, supporting the consideration of non-ambulatory status amongst the strongest risk factors for malnutrition in children with CP, several studies indicated association of higher levels of gross motor impairment with an increased risk of malnutrition and anthropometric deficits in curves in children with CP (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). In addition, children with CP are suggested to have significantly lower anthropometric values in case of severe comorbidities and gastrointestinal problems, emphasizing the potential role of nutritional assessment and management as part of their overall care (<xref rid="B42" ref-type="bibr">42</xref>). The favorable efficacy and tolerability profile of peptide-based enteral formula in our children with severely disabled CP and intolerance on previous tube feeding with standard enteral formula is important in this regard.</p><p>Stunted growth and underdeveloped fat-free mass are considered to be more pronounced in more severe forms of CP, and therefore using screening tools for growth and fat mass is suggested to be more efficient in children with higher the GMFCS levels (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B43" ref-type="bibr">43</xref>). Notably, the combined use of MUAC, age, and GMFCS level is recommended in accurate prediction of weight in children with CP as well as the use of circumferences, primarily MUAC, in combination with other methods (i.e., TSFT) in the anthropometric assessment (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). Accordingly, our findings related to achievement of significantly improved MUAC <italic>z</italic> scores and TSFT <italic>z</italic> scores, as the highly sensitive measures of diagnosing malnutrition in the setting of CP, seem consistent with the multimodal effects of peptide-based enteral formula in terms of bone, muscle, and the adipose panicle (the energetic balance) (<xref rid="B45" ref-type="bibr">45</xref>&#x02013;<xref rid="B48" ref-type="bibr">48</xref>).</p><p>In addition, WFH <italic>z</italic> scores were significantly improved at 6th month in our overall study population as well as in the subgroups of children with &#x0201c;spastic CP and severe activity limitation&#x0201d;, while WFA <italic>z</italic> scores were significantly improved at 6th month in those with &#x0201c;mixed CP and no activity limitation&#x0201d;. These findings seem notable given the increased likelihood of feeding difficulties in children with CP who have more severe motor impairment (i.e., tetraparesis) and more varied motor symptoms (i.e., mixed CP) (<xref rid="B4" ref-type="bibr">4</xref>). Other studies also reported the change in nutritional improvement according to the muscle tonicity in children with CP on PEG tube feeding, such as improved BMI for-age z-score and percent ideal body weight in the hypertonic group but not in the hypotonic group (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>). This emphasizes the possibility of different growth patterns and thus different nutritional support needs depending on the CP type (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>). Also, in a study addressing the factors related to caregiver burden on activities of daily living (ADLs) in 69 children with CP, GMFCS grade and intellectual disability were reported to be associated increased caregiver burden score, whereas, greater difficulty in performing ADLs was noted with lower weight <italic>z</italic> scores, BMI <italic>z</italic> scores and fat mass, regardless of the degree of GMFCS and intellectual disability (<xref rid="B51" ref-type="bibr">51</xref>). Accordingly, in addition to the degree of clinical impairment, nutritional status is also considered a key factor affecting the caregiver's difficulty in performing the ADLs in children with CP (<xref rid="B51" ref-type="bibr">51</xref>).</p><p>Immobile children with 11&#x02005;kcal/cm height/day energy need comprised the majority of our study population in each follow up visit (72.3%, 77.7% and 82.1%, respectively) and the median values for TEE in these children were 1,168&#x02005;kcal/day at baseline and 1,199&#x02005;kcal/day at 1st month. Likewise, in a study among 13 children with CP, nutritional support for four weeks was reported to reveal a significant increase in TEE (from 1,121&#x02005;kcal/day at baseline to 1,189&#x02005;kcal/day at 30 days) (<xref rid="B52" ref-type="bibr">52</xref>). In this regard, our findings support the likelihood of normalization of TEE via an adequate energy intake in children with CP, which is lower than in healthy children due to adaptation of being fed with low energy diets over a prolonged period of time (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>).</p><p>Although, use of PEG (standard polymeric enteral formula) in children with CP has been reported to ameliorate malnutrition with improved anthropometrics, achievement of most of the catch-up growth and nutritional correction in approximately 6 months after PEG tube insertion (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>), a substantial population of children with CP and enteral tube feeding are affected by persistent feeding intolerance (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>). In this regard, our findings highlight the evaluation of gastrointestinal problems together with nutritional status and neurological and neuromuscular impairment in children with CP, since the concomitant presence of constipation, diarrhea, gastroesophageal reflux and feeding intolerance may necessitate alteration in formula and feeding regimens (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B58" ref-type="bibr">58</xref>). Moreover, selecting the appropriate type of enteral formula is of critical importance in maintaining or recovering the nutritional status in children with CP, as a promising strategy to overcome feeding intolerance and to reduce the related adverse health outcomes (i.e., increased risk of severe illness, mortality and nosocomial infections) (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B59" ref-type="bibr">59</xref>).</p><p>In a systematic review of 15 randomized clinical trials on nutritional and dietary interventions in children with CP, the authors suggested that certain dietary and nutritional interventions offer potential benefits in clinical improvement, such as use of whey-based or pectin-enriched enteral formulas for gastroesophageal reflux, supplementation with lipid mixture or diet with high-density energy for improvements in anthropometric measures, supplementation with probiotics, prebiotics, symbiotics or magnesium for constipation and use of a nutritional support system for gross motor function (<xref rid="B60" ref-type="bibr">60</xref>). However, while authors indicated that some promising dietary and nutritional interventions may promote important clinical improvements for patients with CP, they also emphasized that the evidence is weak, due to availability of few published clinical trials along with many methodological errors, leading to a high risk of bias (<xref rid="B60" ref-type="bibr">60</xref>).</p><p>In our children with severely disabled CP and gastrointestinal intolerance, peptide-based enteral formula ameliorated gastrointestinal symptom severity and frequency starting from the 1st month of nutritional support. The improvement in symptom severity was particularly remarkable for discomfort, retching and abdominal distension, while the improvement in symptom frequency was more pronounced for discomfort, nausea, retching and gas. Hence, our findings support the likelihood of protein composition in enteral formulas to ameliorate the gastrointestinal symptoms among gastrostomy-fed children with CP, possibly in relation to effects on gastric emptying and dysmotility (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B61" ref-type="bibr">61</xref>). It has also been suggested that children with CP, frequently having concomitant gastrointestinal problems including foregut dysmotility, may be more sensitive to type of protein in the meal than healthy children (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B62" ref-type="bibr">62</xref>).</p><p>The unique characteristics of MCTs such as not requiring a complex process of digestion and their facile absorption without the need for bile or pancreatic enzymes confer significant advantage over most other lipid molecules, particularly in the setting of gastrointestinal disorders (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>). Besides the amelioration of gastrointestinal intolerance symptoms, peptide-based enteral formula containing MCTs also revealed additional benefits in terms of normalization of bowel movements with a significant decrease in type 1 and a significant increase in type 4 stool patterns in our children. These effects appeared starting from the 1st month of clinical nutrition and maintained throughout the follow up, even in the presence of stomachache, abdominal distension and gas. This seems notable given that chronic constipation in CP has a significant impact on child's well-being, as can be associated with gastrointestinal manifestations (recurrent vomiting, abdominal discomfort and early satiety, compromising dietary intake), urinary symptoms (poorly voiding bladder, recurrent urinary tract infection and deterioration of vesicoureteric reflux) and impaired quality of life (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B65" ref-type="bibr">65</xref>).</p><p>Majority of parents in the current study were satisfied with the study formula, reported significantly improved bowel movements and stool patterns and general status of the child with no adverse reactions and they wished to continue using it. Similarly, evidence of caregiver satisfaction with gastrostomy tube feeding was reported in the majority of studies, including PEG-fed children with CP, regarding the ease of feeding, improvement in child's disposition and nutrition, enhanced child's comfort and abilities, less stress and low risk of long-term adverse events (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>).</p><p>In addition, a high degree of agreement was noted in child feeding and stool patterns as determined by parents and clinicians in the current study, which is important given that family-assessed measurements or family reports, as recently become more popular and important, are considered to be advantageous in terms of providing data not limited to a clinical setting or a visit-time (<xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B68" ref-type="bibr">68</xref>).</p><p>Given that the nutritional status of children with CP is affected by several factors inherent to their own condition and those beyond dietary intake, such as GMFCS level, oral-motor dysfunction, feeding skills, gastrointestinal disorders, physical activity levels and altered energy requirements, multidisciplinary monitoring and evaluation of nutrition support for children with CP has an important role in timely identification and management of nutritional status and potential complications (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>).</p><p>Major strength of the present study seems to be availability of a comprehensive assessment of nutritional and gastrointestinal data in a large-scale cohort of children with CP as well as use of a specialized peptide-based enteral tube feeding in the presence of gastrointestinal intolerance symptoms. Certain limitations to this study should be considered. First, due to observational nature, non-randomized allocation and thereby the likelihood of main selection bias and confounding is possible. Second lack of data on co-morbid gastrointestinal dysfunction such as dysphagia, gastroesophageal reflux and oral motor dysfunction is another limitation which otherwise would extend the knowledge achieved in the current study.</p></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>In conclusion, our findings revealed that choice of a specialized peptide-based formula containing MCT in provision of enteral tube feeding among children with CP and feeding intolerance on previous standard enteral formula is an effective strategy that leads to improved anthropometrics, amelioration of gastrointestinal intolerance, and normalization of bowel movements along with a high parental satisfaction. Our findings suggest that nutritional and gastrointestinal problems should concomitantly be assessed in children with CP and those with concomitant gastrointestinal problems may benefit from provision of enteral tube feeding with use of a specialized peptide-based enteral formula. Hence, appropriate identification of nutritional support needs depending on the clinical and functional CP types is important in children with CP as well as the timely recognition of feeding intolerance that may necessitate alteration in formula and feeding regimens for maintaining or recovering the nutritional status. The utility of specialized peptide-based enteral formulas in enteral tube feeding among children with CP should be further addressed by longer term and larger scale studies in terms of nutritional, gastrointestinal and survival outcomes.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Cagla Ayhan, MD and Prof. Sule Oktay, MD, PhD. from Kappa Training Consultancy Research LL (Izmir, Turkey) who provided editorial support funded by Abbott Nutrition Turkey, Sinan Ozgur Aydin and Evrim Koseoglu from CRM Contract Research Organization (Ankara, Turkey) for statistical analysis funded by Abbott Nutrition Turkey, and Klinar Contract Research Organization (Ankara, Turkey).</p></ack><sec sec-type="data-availability" id="s6"><title>Data availability statement</title><p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.</p></sec><sec sec-type="ethics-statement" id="s7"><title>Ethics statement</title><p>The studies involving humans were approved by Ankara University Faculty of Medicine Clinical Research Ethics Committee (Date of Approval: 24/07/2017; Protocol No: 12-736-17) and the Republic of Turkey Ministry of Health Turkish Medicines and Medical Devices Agency (Date of approval: 16/08/2017; Protocol No: 93189304-514.05.01-E.168888). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants' legal guardians/next of kin.</p></sec><sec sec-type="author-contributions" id="s8"><title>Author contributions</title><p>AK: Conceptualization, Methodology, Project administration, Resources, Supervision, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. GK: Formal Analysis, Methodology, Resources, Writing &#x02013; review &#x00026; editing. GC: Formal Analysis, Methodology, Resources, Writing &#x02013; review &#x00026; editing. CA: Data curation, Investigation, Resources, Writing &#x02013; review &#x00026; editing. NU: Data curation, Investigation, Resources, Writing &#x02013; review &#x00026; editing. GT: Data curation, Visualization, Writing &#x02013; review &#x00026; editing. AY: Resources, Supervision, Writing &#x02013; review &#x00026; editing. CT: Investigation, Writing &#x02013; review &#x00026; editing. AD: Investigation, Writing &#x02013; review &#x00026; editing. FD: Investigation, Writing &#x02013; review &#x00026; editing. MU: Investigation, Writing &#x02013; review &#x00026; editing. SY: Investigation, Writing &#x02013; review &#x00026; editing. DD: Investigation, Writing &#x02013; review &#x00026; editing. EG: Investigation, Writing &#x02013; review &#x00026; editing. BD: Investigation, Writing &#x02013; review &#x00026; editing. YD: Investigation, Writing &#x02013; review &#x00026; editing. NG: Investigation, Writing &#x02013; review &#x00026; editing. HK: Investigation, Writing &#x02013; review &#x00026; editing. FG: Investigation, Writing &#x02013; review &#x00026; editing. ES: Investigation, Writing &#x02013; review &#x00026; editing. AA: Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Visualization, Writing &#x02013; review &#x00026; editing. NE: Investigation, Writing &#x02013; review &#x00026; editing. DT: Investigation, Writing &#x02013; review &#x00026; editing. HA: Investigation, Writing &#x02013; review &#x00026; editing. CC: Investigation, Writing &#x02013; review &#x00026; editing. OG: Investigation, Writing &#x02013; review &#x00026; editing. KD: Investigation, Writing &#x02013; review &#x00026; editing. AU: Investigation, Writing &#x02013; review &#x00026; editing. OB: Investigation, Writing &#x02013; review &#x00026; editing. ZA: Investigation, Writing &#x02013; review &#x00026; editing. MC: Investigation, Writing &#x02013; review &#x00026; editing. AE: Investigation, Writing &#x02013; review &#x00026; editing. NU: Investigation, Writing &#x02013; review &#x00026; editing. CE: Investigation, Writing &#x02013; review &#x00026; editing. SE: Funding acquisition, Project administration, Resources, Visualization, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="s10"><title>Conflict of interest</title><p>AA, SE are Abbott employees.</p><p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s12"><title>Publisher's note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="s11"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fped.2025.1448507/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fped.2025.1448507/full#supplementary-material</ext-link></p><supplementary-material id="SD1" position="float" content-type="local-data"><media xlink:href="Image1.jpeg" id="d100e4946" position="anchor"/></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PB</given-names></name><name><surname>Lambert</surname><given-names>B</given-names></name><name><surname>Rose</surname><given-names>M</given-names></name><name><surname>Ford-Adams</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name><name><surname>Griffiths</surname><given-names>P</given-names></name></person-group>. <article-title>Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study</article-title>. <source>Dev Med Child Neurol</source>. (<year>2000</year>) <volume>42</volume>(<issue>10</issue>):<fpage>674</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1017/s0012162200001249</pub-id><pub-id pub-id-type="pmid">11085295</pub-id>
</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>M</given-names></name><name><surname>Thommessen</surname><given-names>M</given-names></name><name><surname>Rasmussen</surname><given-names>M</given-names></name><name><surname>Selberg</surname><given-names>T</given-names></name></person-group>. <article-title>Feeding and nutritional characteristics in children with moderate or severe cerebral palsy</article-title>. <source>Acta Pediatr</source>. (<year>1996</year>) <volume>85</volume>(<issue>6</issue>):<fpage>697</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.1996.tb14129.x</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calis</surname><given-names>EA</given-names></name><name><surname>Veugelers</surname><given-names>R</given-names></name><name><surname>Sheppard</surname><given-names>JJ</given-names></name><name><surname>Tibboel</surname><given-names>D</given-names></name><name><surname>Evenhuis</surname><given-names>HM</given-names></name><name><surname>Penning</surname><given-names>C</given-names></name></person-group>. <article-title>Dysphagia in children with severe generalized cerebral palsy and intellectual disability</article-title>. <source>Dev Med Child Neurol</source>. (<year>2008</year>) <volume>50</volume>(<issue>8</issue>):<fpage>625</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2008.03047.x</pub-id><pub-id pub-id-type="pmid">18754902</pub-id>
</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a Ron</surname><given-names>A</given-names></name><name><surname>Gonz&#x000e1;lez Toboso</surname><given-names>RM</given-names></name><name><surname>Bote Gasc&#x000f3;n</surname><given-names>M</given-names></name><name><surname>de Santos</surname><given-names>MT</given-names></name><name><surname>Vecino</surname><given-names>R</given-names></name><name><surname>Bodas Pinedo</surname><given-names>A</given-names></name></person-group>. <article-title>Nutritional status and prevalence of dysphagia in cerebral palsy: usefulness of the eating and drinking ability classification system scale and correlation with the degree of motor impairment according to the gross motor function classification system</article-title>. <source>Neurologia (Engl Ed)</source>. (<year>2023</year>) <volume>38</volume>(<issue>1</issue>):<fpage>35</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.nrleng.2019.12.006</pub-id><pub-id pub-id-type="pmid">34836844</pub-id>
</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlseng</surname><given-names>MO</given-names></name><name><surname>Finbr&#x000e5;ten</surname><given-names>AK</given-names></name><name><surname>J&#x000fa;l&#x000ed;usson</surname><given-names>PB</given-names></name><name><surname>Skranes</surname><given-names>J</given-names></name><name><surname>Andersen</surname><given-names>G</given-names></name><name><surname>Vik</surname><given-names>T</given-names></name></person-group>. <article-title>Feeding problems, growth and nutritional status in children with cerebral palsy</article-title>. <source>Acta Paediatr</source>. (<year>2012</year>) <volume>101</volume>(<issue>1</issue>):<fpage>92</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2011.02412.x</pub-id><pub-id pub-id-type="pmid">21767308</pub-id>
</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleigh</surname><given-names>G</given-names></name><name><surname>Brocklehurst</surname><given-names>P</given-names></name></person-group>. <article-title>Gastrostomy feeding in cerebral palsy: a systematic review</article-title>. <source>Arch Dis Child</source>. (<year>2004</year>) <volume>89</volume>(<issue>6</issue>):<fpage>534</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">15155398</pub-id>
</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aydin</surname><given-names>K</given-names></name></person-group>, <collab>Turkish Cerebral Palsy Study Group</collab>. <article-title>A multicenter cross-sectional study to evaluate the clinical characteristics and nutritional status of children with cerebral palsy</article-title>. <source>Clin Nutr ESPEN</source>. (<year>2018</year>) <volume>26</volume>:<fpage>27</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnesp.2018.05.002</pub-id><pub-id pub-id-type="pmid">29908679</pub-id>
</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penagini</surname><given-names>F</given-names></name><name><surname>Borsani</surname><given-names>B</given-names></name><name><surname>Bosetti</surname><given-names>A</given-names></name><name><surname>Mameli</surname><given-names>C</given-names></name><name><surname>Dilillo</surname><given-names>D</given-names></name><name><surname>Ramponi</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Resting energy expenditure in children with cerebral palsy: accuracy of available prediction formulae and development of a population-specific formula</article-title>. <source>Clin Nutr ESPEN</source>. (<year>2018</year>) <volume>25</volume>:<fpage>44</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnesp.2018.04.006</pub-id><pub-id pub-id-type="pmid">29779817</pub-id>
</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PB</given-names></name></person-group>. <article-title>Nutrition and growth in children with cerebral palsy: setting the scene</article-title>. <source>Eur J Clin Nutr</source>. (<year>2013</year>) <volume>67</volume>(<issue>Suppl 2</issue>):<fpage>S3</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/ejcn.2013.222</pub-id><pub-id pub-id-type="pmid">24301006</pub-id>
</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trivi&#x00107;</surname><given-names>I</given-names></name><name><surname>Hojsak</surname><given-names>I</given-names></name></person-group>. <article-title>Evaluation and treatment of malnutrition and associated gastrointestinal complications in children with cerebral palsy</article-title>. <source>Pediatr Gastroenterol Hepatol Nutr</source>. (<year>2019</year>) <volume>22</volume>(<issue>2</issue>):<fpage>122</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.5223/pghn.2019.22.2.122</pub-id><pub-id pub-id-type="pmid">30899688</pub-id>
</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PB</given-names></name></person-group>. <article-title>Pros and cons of gastrostomy feeding in children with cerebral palsy</article-title>. <source>Paediatr Child Health</source>. (<year>2013</year>) <volume>24</volume>(<issue>8</issue>):<fpage>351</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.paed.2013.11.004</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quitadamo</surname><given-names>P</given-names></name><name><surname>Thapar</surname><given-names>N</given-names></name><name><surname>Staiano</surname><given-names>A</given-names></name><name><surname>Borrelli</surname><given-names>O</given-names></name></person-group>. <article-title>Gastrointestinal and nutritional problems in neurologically impaired children</article-title>. <source>Eur J Paediatr Neurol</source>. (<year>2016</year>) <volume>20</volume>(<issue>6</issue>):<fpage>810</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpn.2016.05.019</pub-id><pub-id pub-id-type="pmid">27397730</pub-id>
</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rempel</surname><given-names>GR</given-names></name><name><surname>Colwell</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>RP</given-names></name></person-group>. <article-title>Growth in children with cerebral palsy fed via gastrostomy</article-title>. <source>Pediatrics</source>. (<year>1988</year>) <volume>82</volume>(<issue>6</issue>):<fpage>857</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1542/peds.82.6.857</pub-id><pub-id pub-id-type="pmid">3186375</pub-id>
</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>KD</given-names></name><name><surname>Cox</surname><given-names>K</given-names></name><name><surname>Cannon</surname><given-names>R</given-names></name><name><surname>Blanchard</surname><given-names>D</given-names></name><name><surname>Pitcher</surname><given-names>J</given-names></name><name><surname>Papathakis</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Growth response to enteral feeding by children with cerebral palsy</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. (<year>1990</year>) <volume>14</volume>(<issue>1</issue>):<fpage>23</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1177/014860719001400123</pub-id><pub-id pub-id-type="pmid">2109109</pub-id>
</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauer</surname><given-names>J</given-names></name></person-group>. <article-title>Feeding intolerance in children with severe impairment of the central nervous system: strategies for treatment and prevention</article-title>. <source>Children (Basel)</source>. (<year>2017</year>) <volume>5</volume>(<issue>1</issue>):<fpage>1</fpage>. <pub-id pub-id-type="doi">10.3390/children5010001</pub-id><pub-id pub-id-type="pmid">29271904</pub-id>
</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>RD</given-names></name><name><surname>Conaway</surname><given-names>M</given-names></name><name><surname>Chumlea</surname><given-names>WC</given-names></name><name><surname>Rosenbaum</surname><given-names>P</given-names></name><name><surname>Fung</surname><given-names>EB</given-names></name><name><surname>Henderson</surname><given-names>RC</given-names></name><etal/></person-group>
<article-title>Growth and health in children with moderate-to-severe cerebral palsy</article-title>. <source>Pediatrics</source>. (<year>2006</year>) <volume>118</volume>(<issue>3</issue>):<fpage>1010</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2006-0298</pub-id><pub-id pub-id-type="pmid">16950992</pub-id>
</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brun</surname><given-names>AC</given-names></name><name><surname>St&#x000f8;rdal</surname><given-names>K</given-names></name><name><surname>Johannesdottir</surname><given-names>GB</given-names></name><name><surname>Bentsen</surname><given-names>BS</given-names></name><name><surname>Medhus</surname><given-names>AW</given-names></name></person-group>. <article-title>The effect of protein composition in liquid meals on gastric emptying rate in children with cerebral palsy</article-title>. <source>Clin Nutr</source>. (<year>2012</year>) <volume>31</volume>(<issue>1</issue>):<fpage>108112</fpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2011.07.009</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campanozzi</surname><given-names>A</given-names></name><name><surname>Capano</surname><given-names>G</given-names></name><name><surname>Miele</surname><given-names>E</given-names></name><name><surname>Romano</surname><given-names>A</given-names></name><name><surname>Scuccimarra</surname><given-names>G</given-names></name><name><surname>Del Giudice</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Impact of malnutrition on gastrointestinal disorders and gross motor abilities in children with cerebral palsy</article-title>. <source>Brain Dev</source>. (<year>2007</year>) <volume>29</volume>(<issue>1</issue>):<fpage>25</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2006.05.008</pub-id><pub-id pub-id-type="pmid">16843628</pub-id>
</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>JL</given-names></name></person-group>. <article-title>A pilot intervention study to evaluate compliance to a peptide-based oral nutritional supplement in an adult population with impaired gastrointestinal function</article-title>. <source>Clin Nutr Exp</source>. (<year>2019</year>) <volume>28</volume>:<fpage>123</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.yclnex.2019.08.001</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silk</surname><given-names>DBA</given-names></name><name><surname>Fairclough</surname><given-names>P</given-names></name><name><surname>Clark</surname><given-names>ML</given-names></name><name><surname>Hegarty</surname><given-names>JE</given-names></name><name><surname>Addison</surname><given-names>JM</given-names></name><name><surname>Burston</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Use of a peptide rather than free amino acid nitrogen source in chemically defined &#x02018;elemental&#x02019; diets</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. (<year>1980</year>) <volume>4</volume>(<issue>6</issue>):<fpage>548</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1177/0148607180004006548</pub-id><pub-id pub-id-type="pmid">6780707</pub-id>
</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seres</surname><given-names>DS</given-names></name><name><surname>Ippolito</surname><given-names>PR</given-names></name></person-group>. <article-title>Pilot study evaluating the efficacy, tolerance and safety of a peptide-based enteral formula versus a high protein enteral formula in multiple ICU settings (medical, surgical, cardiothoracic)</article-title>. <source>Clin Nutr</source>. (<year>2017</year>) <volume>36</volume>(<issue>3</issue>):<fpage>706</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2016.04.016</pub-id><pub-id pub-id-type="pmid">27161892</pub-id>
</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>J</given-names></name><name><surname>Layer</surname><given-names>P</given-names></name></person-group>. <article-title>The pathophysiology of malabsorption</article-title>. <source>Viszeralmedizin</source>. (<year>2014</year>) <volume>30</volume>(<issue>3</issue>):<fpage>150</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1159/000364794</pub-id><pub-id pub-id-type="pmid">26288588</pub-id>
</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gantasala</surname><given-names>S</given-names></name><name><surname>Sullivan</surname><given-names>PB</given-names></name><name><surname>Thomas</surname><given-names>AG</given-names></name></person-group>. <article-title>Gastrostomy feeding versus oral feeding alone for children with cerebral palsy</article-title>. <source>Cochrane Database Syst Rev</source>. (<year>2013</year>) <volume>2013</volume>(<issue>7</issue>):<fpage>CD003943</fpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD003943.pub3</pub-id><pub-id pub-id-type="pmid">23900969</pub-id>
</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PB</given-names></name><name><surname>Juszczak</surname><given-names>E</given-names></name><name><surname>Bachlet</surname><given-names>AM</given-names></name><name><surname>Lambert</surname><given-names>B</given-names></name><name><surname>Vernon-Roberts</surname><given-names>A</given-names></name><name><surname>Grant</surname><given-names>HW</given-names></name><etal/></person-group>
<article-title>Gastrostomy tube feeding in children with cerebral palsy: a prospective, longitudinal study</article-title>. <source>Dev Med Child Neurol</source>. (<year>2005</year>) <volume>47</volume>(<issue>2</issue>):<fpage>77</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1017/s0012162205000162</pub-id><pub-id pub-id-type="pmid">15707230</pub-id>
</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PB</given-names></name><name><surname>Alder</surname><given-names>N</given-names></name><name><surname>Bachlet</surname><given-names>AM</given-names></name><name><surname>Grant</surname><given-names>H</given-names></name><name><surname>Juszczak</surname><given-names>E</given-names></name><name><surname>Henry</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Gastrostomy feeding in cerebral palsy: too much of a good thing?</article-title>
<source>Dev Med Child Neurol</source>. (<year>2006</year>) <volume>48</volume>(<issue>11</issue>):<fpage>877</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1017/S0012162206001927</pub-id><pub-id pub-id-type="pmid">17044953</pub-id>
</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>RD</given-names></name></person-group>. <article-title>Use of segmental measures to estimate stature in children with cerebral palsy</article-title>. <source>Arch Pediatr Adolesc Med</source>. (<year>1995</year>) <volume>149</volume>:<fpage>658</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1001/archpedi.1995.02170190068012</pub-id><pub-id pub-id-type="pmid">7767422</pub-id>
</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDowell</surname><given-names>MA</given-names></name><name><surname>Fryar</surname><given-names>CD</given-names></name><name><surname>Ogden</surname><given-names>CL</given-names></name><name><surname>Flegal</surname><given-names>KM</given-names></name></person-group>. <article-title>Anthropometric reference data for children and adults: United States, 2003&#x02013;2006</article-title>. <source>Natl Health Stat Report</source>. (<year>2008</year>) (<issue>10</issue>):<fpage>1</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">25585443</pub-id>
</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><collab>WHO Multicentre Growth Reference Study Group</collab>. <article-title>WHO child growth standards based on length/height, weight and age</article-title>. <source>Acta Paediatr Suppl</source>. (<year>2006</year>) <volume>450</volume>:<fpage>76</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2006.tb02378.x</pub-id><pub-id pub-id-type="pmid">16817681</pub-id>
</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Donnell</surname><given-names>LJD</given-names></name><name><surname>Virjee</surname><given-names>J</given-names></name><name><surname>Heaton</surname><given-names>KW</given-names></name></person-group>. <article-title>Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate</article-title>. <source>Br Med J</source>. (<year>1990</year>) <volume>300</volume>:<fpage>439</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.300.6722.439</pub-id><pub-id pub-id-type="pmid">2107897</pub-id>
</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrew</surname><given-names>MJ</given-names></name><name><surname>Sullivan</surname><given-names>PB</given-names></name></person-group>. <article-title>Growth in cerebral palsy</article-title>. <source>Nutr Clin Pract</source>. (<year>2010</year>) <volume>25</volume>(<issue>4</issue>):<fpage>357</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1177/0884533610374061</pub-id><pub-id pub-id-type="pmid">20702841</pub-id>
</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogarasi</surname><given-names>A</given-names></name><name><surname>Fazzi</surname><given-names>E</given-names></name><name><surname>Smorenburg</surname><given-names>ARP</given-names></name><name><surname>Mazurkiewicz-Beldzinska</surname><given-names>M</given-names></name><name><surname>Dinopoulos</surname><given-names>A</given-names></name><name><surname>Pobiecka</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The PURPLE N study: objective and perceived nutritional status in children and adolescents with cerebral palsy</article-title>. <source>Disabil Rehabil</source>. (<year>2022</year>) <volume>44</volume>(<issue>22</issue>):<fpage>6668</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1080/09638288.2021.1970255</pub-id><pub-id pub-id-type="pmid">34473588</pub-id>
</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tekin</surname><given-names>H</given-names></name><name><surname>Tekg&#x000fc;l</surname><given-names>H</given-names></name><name><surname>Y&#x00131;lmaz</surname><given-names>S</given-names></name><name><surname>Arslangiray</surname><given-names>D</given-names></name><name><surname>Reyhan</surname><given-names>H</given-names></name><name><surname>Serdaro&#x0011f;lu</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Prevalence and severity of malnutrition in pediatric neurology outpatients with respect to underlying diagnosis and comorbid nutrition and feeding related problems</article-title>. <source>Turk J Pediatr</source>. (<year>2018</year>) <volume>60</volume>(<issue>6</issue>):<fpage>709</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.24953/turkjped.2018.06.012</pub-id><pub-id pub-id-type="pmid">31365208</pub-id>
</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soylu</surname><given-names>OB</given-names></name><name><surname>Unalp</surname><given-names>A</given-names></name><name><surname>Uran</surname><given-names>N</given-names></name><name><surname>Dizdarer</surname><given-names>G</given-names></name><name><surname>Ozgonul</surname><given-names>FO</given-names></name><name><surname>Conku</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Effect of nutritional support in children with spastic quadriplegia</article-title>. <source>Pediatr Neurol</source>. (<year>2008</year>) <volume>39</volume>(<issue>5</issue>):<fpage>330</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2008.07.020</pub-id><pub-id pub-id-type="pmid">18940556</pub-id>
</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>A cross-sectional survey of growth and nutritional status in children with cerebral palsy in West China</article-title>. <source>Pediatr Neurol</source>. (<year>2016</year>) <volume>58</volume>:<fpage>90</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2016.01.002</pub-id><pub-id pub-id-type="pmid">27268760</pub-id>
</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caram</surname><given-names>AL</given-names></name><name><surname>Morcillo</surname><given-names>AM</given-names></name><name><surname>Costa-Pinto</surname><given-names>EA</given-names></name></person-group>. <article-title>Nutritional status of children with cerebral palsy in a Brazilian tertiary care teaching hospital</article-title>. <source>Dev Med Child Neurol</source>. (<year>2008</year>) <volume>50</volume>(<issue>12</issue>):<fpage>956</fpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2008.03128.x</pub-id><pub-id pub-id-type="pmid">19160462</pub-id>
</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carman</surname><given-names>KB</given-names></name><name><surname>Ayd&#x00131;n</surname><given-names>K</given-names></name><name><surname>Kilic Aydin</surname><given-names>B</given-names></name><name><surname>Cansu</surname><given-names>A</given-names></name><name><surname>Direk</surname><given-names>MC</given-names></name><name><surname>Durmus</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Evaluation of micronutrient levels in children with cerebral palsy</article-title>. <source>Pediatr Int</source>. (<year>2022</year>) <volume>64</volume>(<issue>1</issue>):<fpage>e15005</fpage>. <pub-id pub-id-type="doi">10.1111/ped.15005</pub-id><pub-id pub-id-type="pmid">34585809</pub-id>
</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000f8;rensen</surname><given-names>SJ</given-names></name><name><surname>Brekke</surname><given-names>G</given-names></name><name><surname>Kok</surname><given-names>K</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>JL</given-names></name><name><surname>Born</surname><given-names>AP</given-names></name><name><surname>M&#x000f8;lgaard</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Nutritional screening of children and adolescents with cerebral palsy: a scoping review</article-title>. <source>Dev Med Child Neurol</source>. (<year>2021</year>) <volume>63</volume>(<issue>12</issue>):<fpage>1374</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.14981</pub-id><pub-id pub-id-type="pmid">34247401</pub-id>
</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>C</given-names></name><name><surname>van Wynckel</surname><given-names>M</given-names></name><name><surname>Hulst</surname><given-names>J</given-names></name><name><surname>Broekaert</surname><given-names>I</given-names></name><name><surname>Bronsky</surname><given-names>J</given-names></name><name><surname>Dall'Oglio</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>European society for paediatric gastroenterology, hepatology and nutrition guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with neurological impairment</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. (<year>2017</year>) <volume>65</volume>(<issue>2</issue>):<fpage>242</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0000000000001646</pub-id><pub-id pub-id-type="pmid">28737572</pub-id>
</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samson-Fang</surname><given-names>L</given-names></name><name><surname>Bell</surname><given-names>KL</given-names></name></person-group>. <article-title>Assessment of growth and nutrition in children with cerebral palsy</article-title>. <source>Eur J Clin Nutr</source>. (<year>2013</year>) <volume>67</volume>(<issue>Suppl 2</issue>):<fpage>S5</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ejcn.2013.223</pub-id><pub-id pub-id-type="pmid">24301007</pub-id>
</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Anaya</surname><given-names>E</given-names></name><name><surname>Angarita-Fonseca</surname><given-names>A</given-names></name><name><surname>Herrera-Galindo</surname><given-names>VM</given-names></name><name><surname>Mart&#x000ed;nez-Mar&#x000ed;n</surname><given-names>RD</given-names></name><name><surname>Rodr&#x000ed;guez-Bayona</surname><given-names>CN</given-names></name></person-group>. <article-title>Association between gross motor function and nutritional status in children with cerebral palsy: a cross-sectional study from Colombia</article-title>. <source>Dev Med Child Neurol</source>. (<year>2016</year>) <volume>58</volume>(<issue>9</issue>):<fpage>936</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.13108</pub-id><pub-id pub-id-type="pmid">27038060</pub-id>
</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunner MLM</surname><given-names>R</given-names></name><name><surname>Cieri</surname><given-names>ME</given-names></name><name><surname>Rodriguez Marco</surname><given-names>MP</given-names></name><name><surname>Schroeder</surname><given-names>AS</given-names></name><name><surname>Cuestas</surname><given-names>E</given-names></name></person-group>. <article-title>Nutritional status of children with cerebral palsy attending rehabilitation centers</article-title>. <source>Dev Med Child Neurol</source>. (<year>2020</year>) <volume>62</volume>(<issue>12</issue>):<fpage>1383</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.14667</pub-id><pub-id pub-id-type="pmid">32893359</pub-id>
</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudokhane</surname><given-names>S</given-names></name><name><surname>Ben Jeddou</surname><given-names>K</given-names></name><name><surname>Migaou</surname><given-names>H</given-names></name><name><surname>Salah</surname><given-names>S</given-names></name><name><surname>Jellad</surname><given-names>A</given-names></name><name><surname>Ben Salah Frih</surname><given-names>Z</given-names></name></person-group>. <article-title>Anthropometric and nutritional assessment of children with severe cerebral palsy: about a Tunisian population</article-title>. <source>Ann Phys Rehab Med</source>. (<year>2015</year>) <volume>58</volume>(<issue>Suppl 1</issue>):<fpage>e141</fpage>. <pub-id pub-id-type="doi">10.1016/j.rehab.2015.07.335</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitney</surname><given-names>DG</given-names></name><name><surname>Gross-Richmond</surname><given-names>P</given-names></name><name><surname>Hurvitz</surname><given-names>EA</given-names></name><name><surname>Peterson</surname><given-names>MD</given-names></name></person-group>. <article-title>Total and regional body fat status among children and young people with cerebral palsy: a scoping review</article-title>. <source>Clin Obes</source>. (<year>2019</year>) <volume>9</volume>(<issue>5</issue>):<fpage>e12327</fpage>. <pub-id pub-id-type="doi">10.1111/cob.12327</pub-id><pub-id pub-id-type="pmid">31237080</pub-id>
</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunner MLM</surname><given-names>R</given-names></name><name><surname>Cieri</surname><given-names>ME</given-names></name><name><surname>Butler</surname><given-names>C</given-names></name><name><surname>Cuestas</surname><given-names>E</given-names></name></person-group>. <article-title>Development of equations and software for estimating weight in children with cerebral palsy</article-title>. <source>Dev Med Child Neurol</source>. (<year>2021</year>) <volume>63</volume>(<issue>7</issue>):<fpage>860</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.14857</pub-id><pub-id pub-id-type="pmid">33694223</pub-id>
</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayd&#x00131;n</surname><given-names>K</given-names></name><name><surname>Dalg&#x00131;&#x000e7;</surname><given-names>B</given-names></name><name><surname>Kansu</surname><given-names>A</given-names></name><name><surname>Ozen</surname><given-names>H</given-names></name><name><surname>Selimo&#x0011f;lu</surname><given-names>MA</given-names></name><name><surname>Tekg&#x000fc;l</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>The significance of MUAC <italic>z</italic>-scores in diagnosing pediatric malnutrition: a scoping review with special emphasis on neurologically disabled children</article-title>. <source>Front Pediatr</source>. (<year>2023</year>) <volume>11</volume>:<fpage>1081139</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2023.1081139</pub-id><pub-id pub-id-type="pmid">36950173</pub-id>
</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mramba</surname><given-names>L</given-names></name><name><surname>Ngari</surname><given-names>M</given-names></name><name><surname>Mwangome</surname><given-names>M</given-names></name><name><surname>Muchai</surname><given-names>L</given-names></name><name><surname>Bauni</surname><given-names>E</given-names></name><name><surname>Walker</surname><given-names>AS</given-names></name><etal/></person-group>
<article-title>A growth reference for mid upper arm circumference for age among school age children and adolescents, and validation for mortality: growth curve construction and longitudinal cohort study</article-title>. <source>Br Med J</source>. (<year>2017</year>) <volume>358</volume>:<fpage>j3423</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.j3423</pub-id><pub-id pub-id-type="pmid">28774873</pub-id>
</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurka</surname><given-names>M</given-names></name><name><surname>Kuperminc</surname><given-names>M</given-names></name><name><surname>Busby</surname><given-names>M</given-names></name><name><surname>Bennis</surname><given-names>JA</given-names></name><name><surname>Grossberg</surname><given-names>RI</given-names></name><name><surname>Houlihan</surname><given-names>CM</given-names></name><etal/></person-group>
<article-title>Assessment and correction of skinfold thickness equations in estimating body fat in children with cerebral palsy</article-title>. <source>Dev Med Child Neurol</source>. (<year>2010</year>) <volume>52</volume>(<issue>2</issue>):<fpage>35</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2009.03474.x</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>M</given-names></name><name><surname>Dain</surname><given-names>E</given-names></name><name><surname>Pelc</surname><given-names>K</given-names></name><name><surname>Dan</surname><given-names>B</given-names></name><name><surname>De Laet</surname><given-names>C</given-names></name></person-group>. <article-title>Nutritional status of neurologically impaired children: impact on comorbidity</article-title>. <source>Arch Pediatr</source>. (<year>2020</year>) <volume>27</volume>(<issue>2</issue>):<fpage>95</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.arcped.2019.11.003</pub-id><pub-id pub-id-type="pmid">31791829</pub-id>
</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>CR</given-names></name><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Eun</surname><given-names>BL</given-names></name><name><surname>Shim</surname><given-names>JO</given-names></name></person-group>. <article-title>Percutaneous endoscopic gastrostomy and nutritional interventions by the pediatric nutritional support team improve the nutritional status of neurologically impaired children</article-title>. <source>J Clin Med</source>. (<year>2020</year>) <volume>9</volume>(<issue>10</issue>):<fpage>3295</fpage>. <pub-id pub-id-type="doi">10.3390/jcm9103295</pub-id><pub-id pub-id-type="pmid">33066538</pub-id>
</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wi&#x00119;ch</surname><given-names>P</given-names></name><name><surname>&#x00106;wirlej-Soza&#x00144;ska</surname><given-names>A</given-names></name><name><surname>Wi&#x0015b;niowska-Szurlej</surname><given-names>A</given-names></name><name><surname>Kilian</surname><given-names>J</given-names></name><name><surname>Lenart-Domka</surname><given-names>E</given-names></name><name><surname>Bejer</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The relationship between body composition and muscle tone in children with cerebral palsy: a case-control study</article-title>. <source>Nutrients</source>. (<year>2020</year>) <volume>12</volume>(<issue>3</issue>):<fpage>864</fpage>. <pub-id pub-id-type="doi">10.3390/nu12030864</pub-id><pub-id pub-id-type="pmid">32213841</pub-id>
</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez de Zabarte Fern&#x000e1;ndez</surname><given-names>JM</given-names></name><name><surname>Ros Arnal</surname><given-names>I</given-names></name><name><surname>Pe&#x000f1;a Segura</surname><given-names>JL</given-names></name><name><surname>Garc&#x000ed;a Romero</surname><given-names>R</given-names></name><name><surname>Rodr&#x000ed;guez Mart&#x000ed;nez</surname><given-names>G</given-names></name></person-group>. <article-title>Carga del cuidador del paciente con par&#x000e1;lisis cerebral moderada-grave: &#x000bf;influyeelestadonutricional? [Caregiver burden in patients with moderate-severe cerebral palsy. The influence of nutritional status]</article-title>. <source>An Pediatr (Engl Ed)</source>. (<year>2021</year>) <volume>94</volume>(<issue>5</issue>):<fpage>311</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.anpedi.2020.06.020</pub-id><pub-id pub-id-type="pmid">32828712</pub-id>
</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Contreras</surname><given-names>AA</given-names></name><name><surname>Vasquez-Garibay</surname><given-names>EM</given-names></name><name><surname>Romero-Velarde</surname><given-names>E</given-names></name><name><surname>Ibarra-Gutierrez</surname><given-names>AI</given-names></name><name><surname>Troyo-Sanroman</surname><given-names>R</given-names></name></person-group>. <article-title>Energy ex-penditure in children with cerebral palsy and moderate/severe malnutrition during nutritional recovery</article-title>. <source>Nutr Hosp</source>. (<year>2015</year>) <volume>31</volume>(<issue>5</issue>):<fpage>2062</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3305/nh.2015.31.5.8588</pub-id><pub-id pub-id-type="pmid">25929375</pub-id>
</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arrowsmith</surname><given-names>FE</given-names></name><name><surname>Allen</surname><given-names>JR</given-names></name><name><surname>Gaskin</surname><given-names>KJ</given-names></name><name><surname>Somerville</surname><given-names>H</given-names></name><name><surname>Birdsall</surname><given-names>J</given-names></name><name><surname>Barzi</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Nutritional rehabilitation increases the resting energy expenditure of malnourished children with severe cerebral palsy</article-title>. <source>Dev Med Child Neurol</source>. (<year>2012</year>) <volume>54</volume>(<issue>2</issue>):<fpage>170</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2011.04166.x</pub-id><pub-id pub-id-type="pmid">22224669</pub-id>
</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Civan</surname><given-names>HA</given-names></name><name><surname>Bektas</surname><given-names>G</given-names></name><name><surname>Dogan</surname><given-names>AE</given-names></name><name><surname>Ozdener</surname><given-names>F</given-names></name></person-group>. <article-title>Percutaneous endoscopic gastrostomy feeding in children with cerebral palsy</article-title>. <source>Neuropediatrics</source>. (<year>2021</year>) <volume>52</volume>(<issue>4</issue>):<fpage>326</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1055/s-0041-1731007</pub-id><pub-id pub-id-type="pmid">34192785</pub-id>
</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dipasquale</surname><given-names>V</given-names></name><name><surname>Catena</surname><given-names>MA</given-names></name><name><surname>Cardile</surname><given-names>S</given-names></name><name><surname>Romano</surname><given-names>C</given-names></name></person-group>. <article-title>Standard polymeric formula tube feeding in neurologically impaired children: a five-year retrospective study</article-title>. <source>Nutrients</source>. (<year>2018</year>) <volume>10</volume>(<issue>6</issue>):<fpage>684</fpage>. <pub-id pub-id-type="doi">10.3390/nu10060684</pub-id><pub-id pub-id-type="pmid">29843419</pub-id>
</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jersak</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Noritz</surname><given-names>G</given-names></name><name><surname>Testa</surname><given-names>M</given-names></name><name><surname>Humphrey</surname><given-names>L</given-names></name></person-group>. <article-title>Defining persistent total parenteral nutrition use in patients with neurologic impairment</article-title>. <source>J Palliat Med</source>. (<year>2022</year>) <volume>25</volume>(<issue>4</issue>):<fpage>577</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1089/jpm.2021.0086</pub-id><pub-id pub-id-type="pmid">34757811</pub-id>
</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCallum</surname><given-names>Z</given-names></name><name><surname>Delany</surname><given-names>C</given-names></name><name><surname>Gillam</surname><given-names>L</given-names></name></person-group>. <article-title>Crossing the line? Ethics of parenteral nutrition in paediatricneurodisability complicated by intestinal failure</article-title>. <source>Arch Dis Child</source>. (<year>2023</year>) <volume>108</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2021-323500</pub-id><pub-id pub-id-type="pmid">35288420</pub-id>
</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrew</surname><given-names>MJ</given-names></name></person-group>. <article-title>Nutrition in children with neurodisability</article-title>. <source>Paediatr Child Health</source>. (<year>2019</year>) <volume>29</volume>(<issue>10</issue>):<fpage>437</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.paed.2019.07.004</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname><given-names>KT</given-names></name><name><surname>Ferreira</surname><given-names>GB</given-names></name><name><surname>Santos</surname><given-names>AT</given-names></name><name><surname>Nomelini</surname><given-names>QSS</given-names></name><name><surname>Minussi</surname><given-names>LOA</given-names></name><name><surname>Rezende</surname><given-names>&#x000c9;RMA</given-names></name><etal/></person-group>
<article-title>Assessment of nutritional status and frequency of complications associated to feeding in patients with spastic quadriplegic cerebral palsy</article-title>. <source>Rev Paul Pediatr</source>. (<year>2020</year>) <volume>38</volume>:<fpage>e2018410</fpage>. <pub-id pub-id-type="doi">10.1590/1984-0462/2020/38/2018410</pub-id><pub-id pub-id-type="pmid">32401853</pub-id>
</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebelo</surname><given-names>F</given-names></name><name><surname>Mansur</surname><given-names>IR</given-names></name><name><surname>Miglioli</surname><given-names>TC</given-names></name><name><surname>Meio</surname><given-names>MDB</given-names></name><name><surname>Junior</surname><given-names>SCG</given-names></name></person-group>. <article-title>Dietary and nutritional interventions in children with cerebral palsy: a systematic literature review</article-title>. <source>PLoS One</source>. (<year>2022</year>) <volume>17</volume>(<issue>7</issue>):<fpage>e0271993</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0271993</pub-id><pub-id pub-id-type="pmid">35867728</pub-id>
</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname><given-names>MD</given-names></name><name><surname>Khoshoo</surname><given-names>V</given-names></name><name><surname>Secker</surname><given-names>DJ</given-names></name><name><surname>Gilday</surname><given-names>DL</given-names></name><name><surname>Ash</surname><given-names>JM</given-names></name><name><surname>Pencharz</surname><given-names>PB</given-names></name></person-group>. <article-title>Decrease in gastric emptying time and episodes of regurgitation in children with spastic quadriplegia fed a whey-based formula</article-title>. <source>J Pediatr</source>. (<year>1992</year>) <volume>120</volume>(<issue>4 Pt 1</issue>):<fpage>569</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-3476(10)80003-4</pub-id><pub-id pub-id-type="pmid">1552396</pub-id>
</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PB</given-names></name></person-group>. <article-title>Gastrointestinal disorders in children with neurodevelopmental disabilities</article-title>. <source>Dev Disabil Res Rev</source>. (<year>2008</year>) <volume>14</volume>(<issue>2</issue>):<fpage>128</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1002/ddrr.18</pub-id><pub-id pub-id-type="pmid">18646021</pub-id>
</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>ND</given-names></name><name><surname>Limketkai</surname><given-names>BN</given-names></name></person-group>. <article-title>The use of medium-chain triglycerides in gastrointestinal disorders</article-title>. <source>Pract Gastroenterol</source>. (<year>2017</year>) <volume>160</volume>:<fpage>26</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Tsujino</surname><given-names>S</given-names></name></person-group>. <article-title>Applications of medium-chain triglycerides in foods</article-title>. <source>Front Nutr</source>. (<year>2022</year>) <volume>9</volume>:<fpage>802805</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2022.802805</pub-id><pub-id pub-id-type="pmid">35719157</pub-id>
</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PB</given-names></name><name><surname>McIntyre</surname><given-names>E</given-names></name></person-group>. <article-title>Gastrointestinal problems in disabled children</article-title>. <source>Curr Paediatr</source>. (<year>2005</year>) <volume>15</volume>(<issue>4</issue>):<fpage>347</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.cupe.2005.04.014</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PB</given-names></name><name><surname>Juszczak</surname><given-names>E</given-names></name><name><surname>Bachlet</surname><given-names>AM</given-names></name><name><surname>Thomas</surname><given-names>AG</given-names></name><name><surname>Lambert</surname><given-names>B</given-names></name><name><surname>Vernon-Roberts</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Impact of gastrostomy tube feeding on the quality of life of carers of children with cerebral palsy</article-title>. <source>Dev Med Child Neurol</source>. (<year>2004</year>) <volume>46</volume>(<issue>12</issue>):<fpage>796</fpage>&#x02013;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1017/s0012162204001392</pub-id><pub-id pub-id-type="pmid">15581151</pub-id>
</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutlu</surname><given-names>A</given-names></name><name><surname>Kara</surname><given-names>&#x000d6;K</given-names></name><name><surname>Livanelio&#x0011f;lu</surname><given-names>A</given-names></name><name><surname>Karahan</surname><given-names>S</given-names></name><name><surname>Alkan</surname><given-names>H</given-names></name><name><surname>Yard&#x00131;mc&#x00131;</surname><given-names>BN</given-names></name><etal/></person-group>
<article-title>Agreement between parents and clinicians on the communication function levels and relationship of classification systems of children with cerebral palsy</article-title>. <source>Disabil Health J</source>. (<year>2018</year>) <volume>11</volume>(<issue>2</issue>):<fpage>281</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.dhjo.2017.11.001</pub-id><pub-id pub-id-type="pmid">29162349</pub-id>
</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutlu</surname><given-names>A</given-names></name><name><surname>Kara</surname><given-names>OK</given-names></name><name><surname>Gunel</surname><given-names>MK</given-names></name><name><surname>Karahan</surname><given-names>S</given-names></name><name><surname>Livanelioglu</surname><given-names>A</given-names></name></person-group>. <article-title>Agreement between parents and clinicians for the motor functional classification systems of children with cerebral palsy</article-title>. <source>Disabil Rehabil</source>. (<year>2011</year>) <volume>33</volume>(<issue>11</issue>):<fpage>927</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.3109/09638288.2010.514645</pub-id><pub-id pub-id-type="pmid">20815692</pub-id>
</mixed-citation></ref></ref-list></back></article>